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Allogeneic transplantation of CB is limited by insufficient number of HSC as 
well as PHPC. An efficient ex vivo expansion of CB can overcome this limitation. An 
ideal ex vivo expansion condition should mimic the in vivo hematopoietic 
microenvironment, which can efficiently expand the cell number while still 
maintaining the “stemness” of the cells.  
MSC, as non hematopoietic, well-characterized skeletal and connective tissue 
progenitor cells within the bone marrow stroma, have been investigated as support 
cells for the culture of HSC/PHPC.  They are attractive for the rich environmental 
signals that they provide and their immunologic compatibility and supporting effect in 
transplantation. In this study we clearly demonstrated the benefit of MSC inclusion in 
HSC expansion ex vivo.  We also compared the contact and non-contact cultures of 
the two cell types; the cell-cell direct interaction was necessary for the efficient 
expansion of HSC.  
HSC-MSC co-cultures have only been performed in 2D configuration. We 
postulate that a 3D culture environment that resembles the natural in vivo 
hematopoietic compartment would be more conducive for regulating HSC expansion. 
The result showed that the direct contact between MSC and HSC in 3D cultures led to 
statistically-significant higher expansion of CB CD34+ cells compared to 2D co-
cultures: 891- versus 545-fold increase in total cells, 96- versus 48-fold increase of 
CD34+ cells, and 230- versus 150-fold increase in CFC. NOD/SCID mouse 
engraftment assays also indicated a high success rate of hematopoiesis reconstruction 
with these expanded cells. This enhanced expansion result was probably due to the 
ECM secreted by MSC, especially FN, which facilitated the interaction with the 
seeded CD34+ cells.  
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Based on this finding, we hypothesize that the immobilization of ECM protein 
FN onto the surface of culture systems might represent another stroma free expansion 
strategy. A key problem in FN immobilization is the change of bioactivity during the 
immobilization process. By comparing the FN bioactivity after two common 
immobilization pathways: conjugation and adsorption, we found that the adsorption 
method maintained a normal conformation of FN, leading to less change of its 
bioactivity in the access of RGD domains and cell adhesion ability. The covalent 
conjugation process, on the other hand, induced FN unfolding and fibrillogenesis ex 
vivo, which blocked the access of active RGD domains and suppressed fibroblast 
cells adhesion. This bioactivity variance on the level of immobilization methods may 
provide us a way to control the function of the immobilized protein, which can be 
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All mature cells in the blood and immune system are derived from HSC and 
all of these cell types can be generated from a single HSC [Osawa et al (1996)]. This 
tremendous potential for reconstituting the hematopoietic system has allowed the 
development of transplantation of HSC as a clinical strategy.  HSC obtained directly 
from the patient (autologous HSC) are used for rescuing the patient from the effects of 
high doses of chemotherapy or used as a target for gene therapy vectors. HSC 
obtained from another person (allogeneic HSC) are used to treat hematological 
malignancies by replacing the malignant hematopoietic system with normal cells. 
Allogeneic HSC can be obtained from siblings (matched sibling transplants), parents 
or unrelated donors (mismatched unrelated donor transplants). Currently, about 
45,000 patients each year are treated by HSC transplantation, a number that has been 
increasing during the past decade.  
There are several different sources for obtaining HSC for transplantation. One 
important new source of HSC is CB that is collected during newborn deliveries. In 
addition to their widespread availability, these HSC have several useful properties, 
including their decreased ability to induce immunological reactivity against the 
patient because of increased levels of immune tolerance in the fetus. Interest in this 
approach has increased since the first successful transplantation of cord-blood HSC in 
1988 [Gluckman et al (1989)], and there are now an estimated 70,000 units of CB that 
are stored and available for transplantation [Gluckman (2001)]. However, their use is 
limited by the number of HSC that can be collected, and it is clear that engraftment is 
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closely correlated with the number of cells that are infused [Wagner et al (2002)]. For 
optimum engraftment, current transplantation requires at least 2,500,000 CD34+ cells 
per kilogram of patient body weight [Koller et al (1993)]. An optimally collected CB 
donation generates approximately 10,000,000 CD34+ cells, which is just 10-15% of 
the optimal dose for an adult. For this reason, CB transplantation is limited to 
pediatric patients right now. Furthermore, because the stem cells in CB are more 
primitive than those in marrow, the hematopoietic recovery using CB stem cells is 
approximately 25 days for neutrophils and 43 days for platelets [Leary et al (1988)], 
which is significantly slower than that obtained in BM transplantation. And it leaves 
the patient vulnerable to a fatal infection for a longer period of time.  
To address these limitations, an effective strategy to expand CB cells ex vivo, 
increasing stem cells for transplantation would considerably improve the therapeutic 
potentials. What’s more, the ex vivo expansion produces more mature precursors, 
supplementing stem cells graft, which help to shorten and potentially prevent 
chemotherapy induced pancytopenia. The purpose of the research presented here is to 
develop a more compatible and efficient system of increasing CB ex vivo expansion, 
while still keeping the stem cells properties. 
 
1.2 Motivation 
The ability of environmental cues to affect stem cell fate is a concept from 
embryology that has been extended to the adult organism with the notion that a highly 
specialized set of conditions exists to regulate the ultimate fate of anatomically 
restricted primitive cells. The physical interaction of stem cells with stroma cells, 
matrix components and supportive factors is thought to define a niche critical for the 
homeostatic maintenance of stem cell populations. For example the HSC changes the 
 2
location during development moving from extra embryonic regions to the aorto-
gonadal-mesonephros in the embryo and then to the liver in the first trimester. By the 
second trimester, BM, spleen and thymus become populated and eventually become 
the exclusive sites of hematopoiesis. With each change in location is an associated 
change in the production emphasis of the stem cell population, with stem cell 
expansion and erythropoiesis in great dominance early and a more balanced, full 
immune repertoire of expansion later. Inspired by the research in hematopoiesis 
microenvironment, we planned to reconstruct the hematopoiesis niche ex vivo for 
more reliable expansion of CB cells. 
 
1.3 Objectives and Scope 
The objective of reconstructing hematopoiesis microenvironment ex vivo for 
more efficient HSC expansion is achieved by the following specific approaches: 
• The incorporation of MSC as stroma in supporting CB expansion (Chapter 4).  
MSC are well characterized skeletal and connective tissue progenitor cells 
within bone marrow. They can provide rich environment signals and show good 
immunological compatibility in transplantation. For these reasons, we incorporated 
MSC into expansion system. First of all, we screened and optimized the co-culture 
conditions, and then we studied on the direct cell-cell contact effect during the co-
culture. The expansion result was evaluated by functional assays ex vivo and in vivo. 
• The incorporation of 3D scaffold in co-culture of CB and MSC (Chapter 5).  
We postulated that 3D culture environment that resembles the natural niche 
would be more conductive for CB expansion, thus we incorporated the 3D scaffold 
into MSC and CB co-culture system. We first screened and optimized the 3D scaffold 
for co-culture, and then we compared the 2D co-culture with 3D co-culture through 
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expansion and functional assays. Finally we studied MSC culture and its ECM 
secretion in 3D scaffold, which probably explained the higher expansion result in 3D. 
• The bioactivity study of immobilized FN, as a supportive research for its 
further application in CB expansion (Chapter 6) 
Inspired by the co-culture result that FN was specially secreted by MSCs in 
supporting CB’s expansion, we hypothesized that the immobilization of FN onto the 
surface of culture system may represent another stroma free expansion strategy. A key 
problem in this strategy is how to control the bioactivity of immobilized FN. In this 
study, we aimed to study the bioactivity of FN after different immobilization 
pathways: conjugation and adsorption. The chemical and physical properties of the 
immobilized surfaces were studied by Micro-BCA, surface contact angle with water 
and AFM. The biological properties of the immobilized surfaces were evaluated by 

















2.1 Review of HSC and its clinic application 
2.1.1 Hematopoiesis and HSC 
Blood cells are responsible for constant maintenance and immune protection 
of every cell type of the body, which can be classified into two main classes, 
lymphoid cells (T, B, and natural killer cells) and myeloid cells (granulocytes, 
monocytes, erythrocytes, and megakaryocytes). All blood cells have a limited lifespan: 
several hours for granulocytes, several weeks for red blood cells, and up to several 
years for memory T cells. Thus, a vast amount of blood cells must be permanently 
produced. In normal adults, the body produces about 2.5 billion red blood cells, 2.5 
billion platelets, and 10 billion granulocytes per kilogram of body weight per day 
[Williams et al (1990)]. Hematopoiesis: the regulated production of eight different 
blood cells is a continual process that is the result of proliferation and differentiation 
of a small common pool of pluripotent cells called HSC, committed progenitor cells, 
and differentiated cells. Within these three stages, extensive expansion of cell 
numbers occurs through cell division. A single stem cell has been proposed to be 
capable of more than 50 cell divisions or doublings and has the capacity to generate 
up to 1015 cells, or sufficient cells for up to 60 years [Kay (1965)]. 
Alexander Maximow, working in St. Petersburg as a military doctor in 1909, 
was the first to suggest that there is a HSC with the morphological appearance of a 
‘lymphocyte’ capable of migrating through the blood to micro-ecological niches that 
would allow them to proliferate and differentiate along lineage specific pathways 
[Maximow (1909]]. The first evidence and definition of blood-forming stem cells 
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came from studies of people exposed to lethal doses of radiation in 1945. Basic 
research soon followed. After duplicating radiation sickness in mice, scientists found 
they could rescue the mice from death with bone marrow transplants from healthy 
donor animals. In the early 1960s, Till and McCulloch began analyzing the bone 
marrow to find out which components were responsible for regenerating blood [Till 
and McCullough (1961)]. They defined what the two hallmarks of an HSC remain: it 
can renew itself and it can produce cells that give rise to all the different types of 
blood cells. For these characters, HSC has huge application in clinics. 
 
Figure 1 Hematopoietic system hierarchy. Dividing pluripotent stem cells (LTR and 
STR) may undergo self-renewal to form daughter cells without loss of 
potential, and also experienced a concomitant differentiation to form 
oligopotent daughter cells (CLP, CMP, and CMP lead to GMP and MkEP) 
with more restricted potential. Continuous proliferation and differentiation 
result in the production of many mature cells. Macrophages are obtained 
from monocytes and similarly platelets are derived from megakaryocytes. 
 
2.1.2 HSC clinic application 
A: Leukemia and Lymphoma 
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Among the first clinical uses of HSC were the treatment of cancers of the 
blood—leukemia and lymphoma, which result from the uncontrolled proliferation of 
white blood cells. In these applications, the patient’s own cancerous hematopoietic 
cells were destroyed via radiation or chemotherapy, and then replaced with a bone 
marrow transplant, or with a transplant of HSC collected from the peripheral 
circulation or the CB of matched donors. 
B: Inherited Blood Disorders  
Another use of allogeneic bone marrow transplants is in the treatment of 
hereditary blood disorders, such as different types of inherited anemia (failure to 
produce blood cells), and inborn errors of metabolism (genetic disorders characterized 
by defects in key enzymes needed to produce essential body components or degrade 
chemical byproducts). The blood disorders include aplastic anemia, beta-thalassemia, 
Blackfan-Diamond syndrome, globoid cell leukodystrophy, sickle-cell anemia, severe 
combined immunodeficiency, X-linked lympho proliferative syndrome, and Wiskott-
Aldrich syndrome. 
C: Cancer Chemotherapy 
Chemotherapy aimed at rapidly dividing cancer cells inevitably hits another 
target—rapidly dividing hematopoietic cells. Doctors may give cancer patients an 
autologous stem cell transplant to replace the cells destroyed by chemotherapy. They 
do this by mobilizing HSC and collecting them from peripheral blood. The cells are 
stored while the patient undergoes intensive chemotherapy or radiotherapy to destroy 
the cancer cells. Once the drugs have washed out of a patient’s body, the patient 
receives a transfusion of his or her stored HSC. 
D: Other Applications  
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For example: One of the most exciting new uses of HSC transplantation puts 
the cells to work attacking otherwise untreatable tumors.  
Most of the therapies above require the use of allogeneic HSC Transplantation, 
as the patients’ own HSC were damaged or dysfunctional. However, there was 
significant risk of patient death soon after the transplantation either from infection or 
from GVHD. Clinics usually try to find a matched donor who is typically a sister or 
brother of the patient who has inherited similar HLA on the surface of their cells to 
reduce the risk. In a study where all patients received an HLA-matched transplant 
from a sibling, and the results were controlled for age, the relative risk of CB versus 
bone marrow was 0.41 for acute GVHD and 0.35 for chronic GVHD[Kondo et al, 
2003]. 
 
2.1.3 Different sources of HSC in transplantation 
A: BM  
The classic source of HSC is bone marrow. For more than 40 years, doctors 
performed bone marrow transplants by anesthetizing the stem cell donor, puncturing a 
bone—typically ilium or iliac bone of pelvis —and drawing out the bone marrow 
cells with a syringe. About 1 in every 100,000 cells in the marrow is a long-term, 
blood-forming stem cell; other cells present include stroma cells, blood progenitor 
cells, and mature and maturing white and red blood cells. 
B: PB 
It has been known for decades that a small number of stem and progenitor 
cells circulate in the bloodstream, but in the past 10 years, researchers have found that 
they can coax the cells to migrate from marrow to blood in greater numbers by 
injecting the donor with a cytokine, such as GCSF. The donor is injected with GCSF a 
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few days before the cell harvest. To collect the cells, doctors insert an intravenous 
tube into the donor’s vein and pass his blood through a filtering system that pulls out 
CD34+ white blood cells and returns the red blood cells to the donor. For clinical 
transplantation of human HSC, doctors now prefer to harvest donor cells from 
peripheral, circulating blood which is easier on the donor—with minimal pain, no 
anesthesia, and no hospital stay. The peripherally harvested cells contain twice as 
many HSC as stem cells taken from bone marrow and engraft more quickly. This 
means patients may recover white blood cells, platelets, and their immune and clotting 
protection several days faster than they would with a bone marrow graft. 
C: CB 
In the late 1980s and early 1990s, physicians began to recognize that blood 
from the human umbilical cord and placenta was a rich source of HSC. This tissue 
supports the developing fetus during pregnancy, is delivered along with the baby, and, 
is usually discarded. Since the first successful umbilical CB transplants in children 
with Fanconi anemia, the collection and therapeutic use of these cells has grown 
quickly. 
Scientists in the laboratory and clinic are beginning to measure the differences 
among HSC from different sources. In general, they find that HSC taken from tissues 
at earlier developmental stages like CB may hold an advantage in telomere length for 
a greater ability to self-replicate, and are less likely to be rejected by the immune 
system—making them potentially more useful for therapeutic transplantation. The 
accepted explanation is that CB carries much less GVHD than bone marrow because 
the newborn baby is "immunologically immature" – for example, the immune system 
has not had time to be exposed to various foreign bodies and develop reactions against 
them [Rocha (2000)].  
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2.2 Review of HSC expansion 
There are three major aspects of stem cell expansion that impact clinical 
feasibility.  
• First is the ability to isolate and characterize an optimal candidate cell 
population for expansion.  
• Second is to define the desired characteristics of the population to be used for 
engraftment including ways to measure those characteristics.  
• Third is the development of reagents and reproducible procedures to support 
the culture of a highly defined cell product for transplantation. 
 
2.2.1 Selection of candidate cells for expansion 
There are a number of issues related to the selection of a candidate stem 
population for ex vivo expansion. Before determining if a protocol results in the 
expansion of a stem cell, one must define what a stem cell is. Based on transplantation 
of marked stem cells in murine model system, a “stem cell” is defined as a cell with 
multi-lineage in vivo hematopoietic reconstituting potential, but has not yet been 
proven in humans. Instead, monoclonal antibodies that react with cell-surface proteins 
on hematopoietic cells have been used to define and isolate populations of candidate 
stem cells phenotypically for further analysis. It is reasonable, though, to assume that 
under ideal conditions one would try to expand the most primitive population that one 
could identify. However, because of the close timing between preparative regimen 
and re-infusion, the standard long-term biological assays for stem cells are impractical 
for quantitating the level of expansion. Therefore, the only practical criteria for 
infusion would likely be based on phenotypic analysis of the expanded product with 
retrospective determination of hematopoietic potential ex vivo. Consequently, it is 
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important to choose a population for expansion that displays a strong correlation 
between phenotype and functional activity. 
It is widely held that the cell-surface glycoprotein CD34 is expressed on 
almost all cells with discernable hematopoietic potential [Krause et al (1996)], as 
determined by ex vivo models of progenitor cell proliferation such as CFC and 
LTCIC assays [Sutherland et al (1990)]. In more recent years, though, additional 
markers have been used to fractionate the CD34+ cells further into lineage-committed 
progenitors and more primitive “stem” cells [Terstappen et al (1991)]. Data from 
evaluation of sub fractions of CD34+ cells indicated that those cells expressing a 
CD34+/CD38- phenotype are highly enriched for very primitive hematopoietic cells 
[Baum et al (1992)]. In general, there is a strong correlation between these cell-
surface phenotypes and biological activity in primary cells isolated from different 
tissue sources (fetal liver and BM, CB, PB).  
 
2.2.2 Evaluation of ex vivo expansion 
Ultimately, preservation of cell function is the determining criteria in the 
success of ex vivo human HSC culture systems. Cell function can be queried ex vivo 
using the CFC and LTC-IC assays, techniques that detect the presence of committed 
and multi potent cells on the basis of the formation of morphologically distinguishable 
colonies either directly in methylcellulose cultures (CFC), or after greater than 5 
weeks on stroma feeder layers (LTC-IC) [Hogge et al (1996)]. In vivo functional 
assays for HSC have been developed on the basis of the ability of these cells to 
reconstitute hematopoiesis in the BM of SCID/NOD mice following intravenous 
injection [Vormoor et al (1994)]. These so-called NOD/SCID-repopulating cells are 
considered human HSC that home to and engraft the murine bone marrow, where they 
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subsequently proliferate and differentiate into multiple lineages [Cashman et al 
(1997)]. 
 
2.2.3 Expansion systems 
HSC must maintain a balance between self-renewing cell divisions (needed to 
ensure their existence throughout the life of an organism) and differentiation (needed 
to replace the loss of mature cell populations).The successful maintenance and 
expansion of transplantable HSC ex vivo requires triggering stem cells to proliferate 
without undergoing differentiation. Cultured HSC must additionally avoid apoptosis 
and maintain the ability to home, engraft, and differentiate into appropriate receptive 
tissues. Because the regulation of these processes involves interactions between cell-
surface receptors and a large group of soluble and matrix bound modulators of cell 
function, many investigators have focused on developing culture systems 
supplemented with stroma, appropriate combinations of stimulatory factors to 
maintain and expand HSC ex vivo. Primarily the ex vivo expansion processes can be 
divided into two groups: stroma dependent and stroma independent. 
 
2.2.3.1 Stroma dependent expansion 
Before the development of recombinant human cytokines, in the traditional 
cultivation process, a stroma layer was known to produce ECM components and 
growth factors to support PHPC expansion. The first successful hematopoietic culture 
was performed by Dexter’s group, who used murine BM to develop a confluent 
stroma layer [Dexter et al (1973)]. The addition of hydrocortisone to the medium 
allowed the development of human BM stroma layers, which were found to support 
HSC expansion from a variety of sources. [Quesenberry et al (1991)]. A second 
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source of BM or CB cells could be used to initiate this two-step stroma culture. 
Gartner [Gartner and Kaplan (1980)] first identified conditions for the simultaneous 
development of a stroma layer and stroma dependent hematopoiesis, a system which 
is now termed one-step stroma culture. Both types of stroma cultures support HSC 
expansion for a prolonged time period, but after approximately 6-8 weeks, the stroma 
layer begins to lose integrity and hematopoiesis stopped. Recently the use of FGF-4 
has been found to enable faster development and longer maintenance of healthy 
stroma layer [Quito et al (1996)].  
The finding that more frequent medium exchange increase the productivity of 
stroma cultures [Schwartz et al (1991)] led to the development of perfusion bioreactor 
systems. The first two perfusion systems consisted of flat bed chambers containing 
stroma co-cultures that were perfused with media. They successfully increased the 
expansion of total cells, CFC, and LTC-IC compared with static controls [Koller et al 
(1993)].  A number of other reactor systems have been used with less success. 
Sardonini and Wu investigated the use of stirred micro carrier, airlift and hollow fiber 
systems for the culture of BM MNC and CD34+ cells, in all cases they found poor 
expansion compared with static cultures [Sardonini and Wu (1993)]. An airlift 
packed-bed system was used for murine BM cultures, but this required the use of 
exogenous stroma-conditioned medium, and the cells were difficult to harvest from 
the packed bed [Highfill et al (1996)]. A micro porous collagen-sphere perfusion 
system has been developed for BM cultures, but an unidentified factor has been 
shown inhibit the production of CFU-GM colonies [Wang et al (1995)]. 
Though use of stroma cells in ex vivo culture is advantageous for maturation 
and attainment of functional properties in progenitor cells, stroma may pose several 
disadvantages in clinical applications: (1) the use of allogeneic source of stroma cells 
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could be potentially harmful due to additional loading of miss-matched tissue, for 
example GVHD and donor-mediated infection, (2) ex vivo expansion of PB/CB stem 
cells for autologous transplantation requires an additional invasive harvest of patient 
bone marrow to produce a preformed stroma layer, and (3) due to the adherent nature 
of progenitor stem cells harvesting of cells may require harsh treatment that could be 
detrimental to the desired cells.  
 
2.2.3.2 Stroma independent expansion 
 With the advent of recombinant cytokines and CD34+ selection technologies, 
it became possible to develop stroma-free culture systems with significant expansion 
of hematopoietic cells. Most of these cultures have been performed in well-plates and 
T-flasks utilizing CD34+ cells. For the scale-up of these cultures for clinical trials, 
most investigators have chosen to use large culture bags, in which cells grow 
undisturbed until harvest. It has been demonstrated that CD34+ cells or MNC cultured 
in these environments produce qualitatively indistinguishable cells [Koller et al 
(1995)].  
  A modification of a flat-bed culture chamber has allowed the development of 
stroma-free hematopoietic perfusion culture [sandstorm et al (1996)]. The chamber 
contains multiple microgrooves (perpendicular to the direction of the flow of medium) 
that allow the diffusion of nutrition but retain cells in the chamber. Considerable 
success has also been demonstrated in a stirred spinner flask culture at low agitation 
rates using a high seeding density of BM MNC. Although there is no stroma layer in 
this stirred system, it was demonstrated that the culture maintained and expanded 
stroma cells precursors in suspension along with hematopoietic progenitors. Stirred 
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suspension systems have also been successfully used for both serum containing and 
serum free culture of PB cells and CB cells.  
Despite many of the positive effects of stroma cells can be partly substituted 
by either stroma conditioned medium or recombinant growth factors, in the absence 
of stroma support, the expansion of CB based on HGF-supplemented culture has been 
suboptimal. Phase I clinical trials conducted on UCB expanded in cytokine-
supplemented culture have failed to demonstrate more rapid hematopoietic recovery 
in CB recipients [Pecora et al (2000); Kogler et al (1999); Koller et al (1998)]. This 
suggests a loss of stem cell function in the cytokine-based expansion in spite of an 
increase in CD34+ cell dose. These observations corroborate recent advances in the 
cellular and molecular mechanisms underlying the regulation of stem cell 
differentiation, indicating that microenvironment or stem cell “niche” is crucial for 
maintenance of self-renewal capacity of stem cells [Gupta et al (2000); Kiger et al 
(2000); Tran et al (2000)]. 
 
2.3 Review of HSC microenvironment 
In mammals, hematopoiesis occurs in the extra vascular spaces between 
marrow sinuses, in a specialized area, known as niche. The stem cells niche is yet to 
be described in the ultra structure level, but it is believed that niches provide 
microenvironment to meet certain functional requirements of hematopoiesis. The 
microenvironment is characterized by the local geometry and cellular arrangement, by 
stroma cells, by the chemical nature of the microenvironment in terms of cytokines 
and ECM components.  
 
2.3.1 Cytokine microenvironment 
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The cytokine microenvironment in these cultures is dynamic [Zandstra et al 
(1997)], with multiple cell types competing for cytokines and nutrients, many of 
which are capable of influencing stem cell fate directly or indirectly. These complex 
interactions make the cytokine composition of HSC expansion medium particularly 
challenging to optimize. Furthermore, as culture time progresses, the composition of 
the culture system can change dramatically and the endogenous production of factors 
that have a suppressing effect on HSC self-renewal may significantly influence 
culture output. Designing successful HSC expansion cultures thus requires strategies 
to maintain an appropriate balance between stimulatory and inhibitory modulators of 
HSC function. 
Positive modulators of HSC function 
Among the different stimulatory cytokines identified in the above mentioned 
and other studies, combinations of SCF, FL, and TPO have been shown to be 
particularly effective in eliciting self-renewal divisions of human HSC.  
SCF, the ligand for the tyrosine kinase receptor c-Kit, promotes the survival 
and growth of primitive hematopoietic progenitors when used in combination with 
other stimulatory cytokines [Broudy (1997)]; little expansion is observed in cultures 
supplemented with SCF alone [Ohmizono et al (1997)].  
FL, a factor secreted by stroma cells and which has documented similarities to 
SCF, has also been extensively investigated as a potential mediator of HSC expansion 
and maintenance [Lyman and Jacobsen (1998)]. FL is believed to act by recruiting 
HSC into the cell cycle [Haylock  et al (1997)] and by promoting survival, 
presumably through inhibition of apoptosis [Meyer and Drexler (1999)].  
TPO supports the proliferation and long term maintenance of primitive 
hematopoietic progenitors and repopulating HSC when used in combination with 
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other stimulatory cytokines [Won et al (2000)]. When used alone, TPO has little 
effect on the expansion of HSC in suspension cultures. However, in the presence of 
stroma cells, TPO may promote sustained HSC expansion.  Thus, TPO may play a 
key role in the long-term maintenance and development of primitive HSC in vivo, and 
may be a useful additive for successful HSC expansion ex vivo [Luens et al (1998)]. 
Although most studies have focused on “hematopoietic” cytokines, other 
groups have identified novel factors, not originally identified as a result of their 
effects on hematopoietic cells that may regulate HSC responses. For example, Bhatia 
et al. [Bhatia et al (1999)] reported that BMP can modulate the proliferation and 
differentiation of primitive human hematopoietic cells and that BMP type-1 receptors 
were expressed, along with downstream transducers of the BMP signaling pathway, in 
subpopulations of hematopoietic progenitors. Recently, the addition of the Notch 
ligand, Jagged-1, to cultures of primitive progenitor cells induced the survival and 
expansion of repopulating HSC [Karanu et al (2000)] implicating Jagged-1 as another 
novel growth factor for the modulation of human HSC function [Varnum et al (2000)]. 
Negative modulators of HSC function 
In spite of extensive investigations, ex vivo expansion systems supplemented 
with combinations of stimulatory cytokines have not, to date, yielded sustained HSC 
growth, suggesting that HSC expansion may be limited by other factors. Ex vivo 
production of inhibitory proteins is one potential reason for the transient expansion 
observed in many cultures. Protein factors, such as TGF-b, TNF-a, and, more recently, 
IL-3 have been shown to decrease repopulating potential by inducing differentiation 
or apoptosis, as well as by decreasing the ability of repopulating stem cells to migrate 
to the bone marrow microenvironment. For these inhibitory cytokines to affect HSC 
growth ex vivo, they must be generated in culture. Evidence showing that this occurs 
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has been obtained from the analysis of hematopoietic progenitor cultures, where both 
mRNA and protein expression of inhibitory and stimulatory factors have been 
measured from stroma and progenitor cell populations [Majka et al (2001)]. 
 
2.3.2 Stroma microenvironment 
The stroma cells include endothelial cell that line the marrow sinuses, 
adventitial reticular cells, macrophages, and adipocytes. These stroma cells synthesize 
growth and differentiating factors, and ECM components. The stroma cells and the 
ECM form 3D scaffolding upon which the HSC lodge. The stroma cells through their 
intimate physical contacts with the hematopoietic cells, through the ECM components 
and the growth factors they secrete create an intricate hematopoietic inductive 
microenvironment, which promotes and regulates hematopoiesis [Dexter (1989)]. It is 
this type of inductive microenvironment is termed hematopoietic niche. 
Endothelial cells have been observed to produce constitutively G-CSF and 
GM-CSF [Brockbank et al (1986)]. They are also capable of transporting plasma 
derived substances through their cytoplasm into the hematopoietic space. Adventitial 
reticular cells are fibroblastoid cells that ectopically synthesize a number of growth 
factors, e.g., G-CSF, M-CSF, GM-CSF, IL-1, IL-6, SCF, FL, LIF [Bianco et al 
(2001)].Adventitial reticular cells are capable of taking up fat in the presence of 
corticosteroids and converted into adipocyte [Greenberger (1978)]. In young age 
marrow is red in color and cellular, with the age hematopoietic activity is reduced and 
the marrow is composed of large proportion of fat cells (yellow marrow) [Tavassoli et 
al (1974)]. Macrophages are critical in controlling erythropoiesis, which proceeds in 
isolated islets surrounding an associated macrophage nurse cell in the BM [Crocker 
and Gordon (1987)].Macrophages are considered to be a major source of cytokines 
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under normal conditions; these are, GM-CSF, IL-1 EPO [Rich (1988)]. They also 
produce hematopoiesis inhibitory cytokine like, TNFa and IFNg.  
 
2.3.3 ECM microenvironment 
In BM, ECM components are mainly produced by endothelial and adventitial 
reticular cells. The ECM of BM consists of collagen types I, II, IV [Zuckerman and 
Wicha (1983)], laminin, FN [Bentley and Tralka (1983)], vitronectin [Coulombel et al 
(1988)], thrombospondin [Long and Dixit (1990)], hemonectin [Campbell et al 
(1987)], and proteoglycans with glucosaminoglycan side chains, such as heparan 
sulfate and hyaluronic acid [Gordon et al (1988)]. ECM provides support and 
cohesiveness for the marrow structure. There is a growing body of evidence 
indicating that ECM is important for the regulation of hematopoiesis. For example 
glucosaminoglycan side chains of heparan sulfate can sequester and compartmentalize 
certain cytokines in local areas and present them to HSC [Roberts et al (1988)]. This 
is the mechanism for presenting high, localized concentrations of growth factors that 
are protected from proteolysis. Another important function of ECM is to provide 
anchorage for immature hematopoietic cells. 
 
2.3.4 3D topology 
The successful reconstitution of long-term ex vivo hematopoiesis can perhaps 
be best simulated by mimicking in vivo conditions. As mentioned earlier, the 
hematopoietic microenvironment is composed of different stroma cells that secrete 
ECM components and various soluble growth factors distributed in three-dimensional 
space. Thus it was hypothesized that growth of stem cells on a three-dimensional 
culture system will be a close replica of hematopoietic microenvironment.  
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Following the concept of the three-dimensional culture system, in 1998, 
Mantalaris et al. reported culture of human bone marrow cells on porous collagen 
sphere in a packed-bed bioreactor [Mantalaris et al (1998)]. Mononuclear cells of 
healthy adult donors were cultured on collagen macro porous spheres in the presence 
of SCF, IL-3, GM-CSF, IGF-I, and EPO for four weeks. A few significant 
observations extracted from this report are: (a) microscopic examination of the thin 
section reveals that the marrow cells populated the pores of the micro spheres in a 3D 
fashion with cell-to-cell contact and the resulting interactions resembled the bone 
marrow tissue structure in vivo; (b) morphological and staining techniques ensured 
the presence of erythroblastic islands of matured red cells and monocytes; (c) no 
adipocytes and blanket cells were observed in this culture. In this culture system, cells 
of all lineages were present in significant levels, as compared to the 2D Dexter’s 
culture.  
In the recent past, two different three-dimensional culture systems were 
reported for hematopoietic stem cells. The first was tantalum coated porous carbon 
matrix, known as Cellfoam [Banu et al (2001)], and the other was non woven PET 
fabric [Li et al (2001)]. It was shown that low concentrations of early acting cytokines 
SCF and FL result in higher yields of cells that were enriched with primitive 
progenitor and multipotent hematopoietic progenitor cells in a 3D Cellfoam bioreactor 
as compared to plastic culture flasks. Similarly, 3D non woven PET matrix was 
reported to produce two- to three fold more CD34+ cell when compared with the 2D 
system in seven to nine weeks culture in the presence of TPO and FL. It was also 
shown that both stroma and hematopoietic cells were distributed spatially within the 
scaffold and facilitated cell-cell and cell-matrix interactions closure to the in vivo 
bone marrow microenvironment. Despite the feasibility of culturing progenitor cells 
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on 3D supports, this system was limited by the problems such as insufficient 
expansion of mononuclear cells and difficulties in harvesting cells from the scaffold 
matrix. 
 
2.4 Protein immobilization and bioactivity study 
In the past twenty years different strategies were utilized to immobilize 
functional protein like FN onto varied biomaterials surface. Adsorption was the most 
commonly adopted method. Although less stable and less controllable, adsorption is 
partially reversible leading to a relatively slow change of conformation of the 
adsorbed molecules and a slow release of adsorbed molecules through exchange 
reactions. The pioneering work of Grinnell and Feld in the study of adsorption 
characteristics of plasma FN reported the higher adsorption and lower bioactivity of 
FN on the hydrophobic substrate than on the hydrophilic surfaces [Grinnell and Feld 
(1982)]. And it was confirmed by the following studies [George et al (2004); 
Kowalczynska et al (2005)].  
Recently there has been interest to immobilize FN to surfaces using covalent 
coupling chemistries via the amine, thiol, and aldehyde groups [Staffan et al (1997); 
Biran et al (2001)]. Covalent coupling presumably would be more efficient and stable 
against detachment. A critical issue of the covalent strategy is the conservation of the 
desired bioactivity of the immobilized FN. The degree of activity depends on the 
binding procedure and the substrate. A combination of conjugation and adsorption can 
sometimes produce the optimal results. By conjugating FN to the terminals of 
PluronicTM F108 adsorbed on polystyrene, Biran et al. concluded that the FN was 
more bioactive than the FN adsorbed directly onto polystyrene as revealed by the 
neurite adhesion and outgrowth assay [Biran et al (2001)].  
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However, comparing the adsorption method with the covalent conjugation 
approach in the literature is difficult because of the different chemistries and surfaces 
used. In addition, the presence of serum and trypsin in the cell adhesion study, which 
may alter the composition of the immobilized protein [Andrade and Hlady (1986)] or 























MATERIALS AND METHODS 
 
3.1 Materials  
3.1.1 Biological materials 
CB CD34+ cells were purchased from AllCell Inc. (San Mateo, CA, USA) and 
thawed according to reference [Rubinstein et al (1995)]. The purity of CD34+ cell was 
91% with a viability of 95%. Recombinant human SCF, FL-3, TPO and IL-3, the 
media used in hematopoietic stem cell expansion (StemSpan SFEM Medium) and 
CFC assay (MethoCult GF+ H4435) were all purchased from StemCell Technologies 
(Vancouver, BC, Canada). Purified human bone marrow MSC and MSC Growth 
Medium - MSCGM PoieticsTM were purchased from Cambrex Bio Science 
(Walkersville, MD, USA). BHK21 cell line was obtained from Cambrex Walkersville 
Inc. (Maryland, USA). RPMI 1640 medium, FBS, penicillin and streptomycin were 
purchased from Sigma Aldrich (St. Louis, USA). 
 
3.1.2 Chemical materials 
Bi-axially oriented PET films about 100um thickness were purchased from 
Goodfellow Inc. (Cambridge, UK). Sterilized SEFAR PETEX 07-1/2 PET woven 
mesh was purchased from Sefar Ltd. (Singapore) or Non woven PET Fibra-Cel® was 
purchased from New Brunswick Scientific Co. Inc. Human plasma lyophilizated and 
sterile FN, MTT were purchased from Roche Ltd. (Indiana, USA). Ethylenediamine, 
Glutaradehyde, Ethanolamine, cyanoborohydride, were obtained from Sigma-Aldrich 
Co. (St. Louis, USA). Micro BCA, BCA, Goat anti-rabbit IgG peroxidase conjugated 
were obtained from PIERCE Biotechnology Inc. (Rockford, USA). 24/96 wells tissue 
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culture plate was from NUNC. Anti-VCIP, RGD domain, Human (rabbit) was 
purchased from Oncogene Science Inc. (Cambridge, USA). Monoclonal anti-collagen 
type I and IV, monoclonal anti-laminin, monoclonal anti-FN, and secondary antibody 
were purchased from Sigma (Saint Louis, Missouri USA). CellTracker Green 
CMFDA was purchased from Molecular Probes, Inc (Eugene, OP, USA) 
 
3.2 MSC and CB CD34+ cells co-culture 
3.2.1 MSC culture  
Cryopreserved cells were thawed and plated in tissue culture flask (Nunc, New 
York, USA). Adherent MSCs were maintained in MSCGM, and were harvested when 
they reached 80-90% confluence with 1X trypsin/EDTA solution PBS for 5 min, and 
then were diluted and inoculated into a fresh tissue culture flask. Cells of passage 
around 4 were used for co-culture.  
 
3.2.2 Ex vivo expansion of CB CD34+ cells in co-culture systems 
For the 2D (contact) co-culture, MSCs (2.5 x 104 cells) were seeded into each 
well of a 24 well plates (Nunc, New York, USA) and grown to confluence. After 
washing 3 times with PBS, 600 CB CD34+ enriched cells suspended in 600µl 
StemSpan SFM containing 40ug/ml low density lipoprotein (from Academy 
Biomedical Company; Houston, USA), 100ng/ml SCF, 100ng/ml FL-3, 50ng/ml TPO, 
and 20ng/ml IL-3 were seeded onto the MSC layer in each well. The cells were 
cultured for 10 days without medium change at 37oC and 5% CO2. Plain 24-well plate 
without the MSC layer was used as a control (2D or TCPS control). 
For non-contact co-cultures (Transwell co-culture), MSC feeder layer was 
prepared in 24-well plates as described above and incubated in 600ul of supplemented 
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StemSpan medium. A Nunc CC Insert (sterile Polycarbonate membrane, 0.4um pore 
sized, pore density 1.5 x 108 pores per cm2,  film thickness 20 microns, height above 
the base of well 1mm, culturing area 0.5cm2), was placed into each well and seeded 
with 600 CB CD34+ enriched cells in an additional 600 ul of supplemented StemSpan 
medium. 10 days expansion at 37oC and 5% CO2. Plain 24-well plate with cell insert 
was used as a control (Transwell control). 
For irradiated MSC co-culture: MSCs were harvested and given irradiation at 
15 Gy from a 60Co source.  1 x 105 irradiated cells were seeded into each well of 24-
well plates and formed confluent layer. After 24 hours adhesion, the adherent layers 
were washed 3 times with PBS. 600 CB CD34+ enriched cells were added to the 
feeder layer, with 600µl supplemented StemSpan medium as described above.  
For MSC pellet co-culture: harvested MSCs were incubated in high density at 
37ºC over night. After the formation of stable pellets, the MSC pellets were 
transferred to the tissue culture plates. After 24 hours adhesion, the adherent pellets 
were washed 3 times with PBS. 600 CB CD34+ cells were added to each well of 24-
well plates, suspended in 600µl supplemented StemSpan medium as described above.  
At the end of 10-day expansion, cells were harvested by repeated pipetting and 
counted using a hemacytometer. Antibodies against CD34, CD45 and other mature 
cell surface markers (CD38, Glycophorin A [GlyA], CD15, CD3, CD19 from Becton-
Dickinson and CD41 from Dako) were incubated with cells on ice for 30 min and 
analyzed using the FACSCalibur (Becton-Dickinson). At least 20,000 events were 
acquired for each analysis. Analysis of flow cytometry data was carried out using 
CellQuest Pro. CD34+, CD34+CD38- percentages were calculated as percentages of 
blood cells gate (set on CD45+, low side scatter cells of the expanded cells, and 
maintained throughout analysis). 
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3.2.3 CFC 
After a 10-day culture, 1-3×103 expanded cells or 300-500 unexpanded cells 
were harvested and transferred to 1.1 ml H4435 medium and plated 35-mm sterile 
Petri dishes (StemCell Technologies).  After incubation for 14 days at 37°C in a 
humidified atmosphere at 5% CO2, granulocyte-macrophage, erythroid and multi-
lineage colony-forming cells (CFC-GM, CFC-E and CFC-GEMM) were counted 
under an inverted microscope.  
 
3.2.4 Animal engraftment 
NOD/ SCID mice were purchased from Jackson Laboratories (Animal 
Resource Centre in Perth, Australia) and maintained at the animal holding unit of 
National University of Singapore. All animals were handled according to Institutional 
regulations, under sterile conditions and maintained in micro-isolator cages. Mice to 
be transplanted were given total body irradiation of 350 cGy from a 60Co source at 
age of 6 to 8 weeks. Within 24 hours, expanded cells were harvested and injected into 
the tail vein of the irradiated mice. 2×105 human bone marrow CD34 depleted cells 
were irradiated with 1500cGy and injected together as carrier cells.  
To assess the engraftment efficiency of the expanded human cells, mice were 
sacrificed 6 weeks after transplantation. Bone marrow cells were flushed from both 
femurs and tibias with HBSS containing 2% FBS and 5% human serum using a 
syringe and a 26-gauge needle. Red blood cells were lysed with 0.16M ammonium 
chloride and the remaining cells were washed with HBSS supplemented with 2% FBS. 
To facilitate blocking of Fc receptors and prevent nonspecific binding of antibodies, 
cells were suspended in HBSS with 2% FBS and 5% human serum and incubated 
with mouse 2.4G2 MAb (Becton-Dickinson) for 10 min at 4°C. Cells were then 
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incubated with PerCP-Cy5.5-labeled monoclonal antibodies specific for human CD45 
for 30 min at 4°C. Analysis was performed using a FACScalibur and more than 
40,000 events were acquired. Successful engraftment of human hematopoietic stem 
cell was defined by the presence of at least 0.2% of human CD45+ cells. To verify the 
multi-lineage re-constitution of human cells, additional staining was performed with 
anti-human CD19-PE /CD41-FITC / CD13-PE / GlyA-PE in combination with anti-
human CD45-PerCP-Cy5.5.  
 
3.3 MSC and CB CD34+ cells 3D co-culture 
3.3.1 MSC culture in 3D system and assays 
Sterilized SEFAR PETEX 07-1/2 poly PET woven mesh (Sefar Singapore Pte. 
Ltd., Singapore) or Non woven PET Fibra-Cel® (New Brunswick Scientific Co. INC) 
were used as scaffolds for cell culture. The PET mesh was cut and fitted into the wells 
of a 24-well plate. MSCs (2.5 x 104 cells) were seeded into the mesh, grown to 
confluence.  
SEM:  
The cultured samples were fixed with 3% glutaraldehyde in PBS for 24 hours, 
washed with PBS, followed by osmification in 1% OsO4 for 30 minutes. After 
dehydration in a graded ethanol series, the samples were dried in a critical-point dryer. 
After sputter coating with gold, the samples were examined using a SEM (JSM-
5660LV).  
Confocol imaging:  
For confocal microscopy (Zeiss 510 meta), the cultured samples were first 
stained with CMFDA, then fixed with 1% PFA. After that they were stained with 
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antibody for 30 minutes (repeat staining for the use of secondary antibody).After 
extensively washing, the samples were examined. 
Cell attachment, proliferation and protein production assay for MSC 
MSCs (25,000 per well) were seeded into 24-well tissue culture plate with or 
without PET mesh. After 24-hr incubation, cells were harvested and counted in 
hemacytometer. The result was expressed as attachment percentage of the seeded cells. 
Cell proliferation was determined after 4 days of incubation, when the cells reached 
~90% confluence. Cell protein production was determined by the BCA™ protein 
assay (Pierce, IL, USA). After 4 days incubation, the confluent MSC layer was 
washed by PBS and lysed in 300ul of 4% SDS. After centrifugation, 50ul supernatant 
was mixed with 200ul BCA working solution and incubated at 37ºC for 30 min. The 
total protein level was then measured by UV absorbance at 562nm. The result was 
expressed as equivalent albumin production (ug) per 10000 cells.  
 
3.3.2 Ex vivo expansion of CB CD34+ cells in 3D systems and functional assays 
MSCs (2.5  x 104 cells) were seeded into the mesh, grown to confluence, 
washed 3 times with PBS, and then 600 CD34+ enriched cells were seeded in the 
same medium described above. Plain PET woven mesh without MSC layer was used 
as a control (3D control). The other functional assays followed the above procedures. 
 
3.4 Study of FN immobilization bioactivity 
3.4.1 FN conjugation and adsorption 
Figure 2 showed the scheme of FN immobilization. In conjugation pathway, 
clean PET surface aminated by ethylenediamine solution (ethylenediamine: 
ethanol=1:1) at 50ºC for 40 minutes, was immersed in freshly prepared 2% 
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glutaraldehyde solution with 0.05M sodium cyanoborohydride,  reacted for 12-20 
hours at room temperature. After washing, the glutaradehyde conjugated surface was 
transferred to FN solution in sodium carbonate buffer with 0.05M sodium 
cyanoborohydride, reacted for 24 hours at room temperature. To block unreacted 
aldehyde sites, 0.06M ethanolamine was added and reacted for another 12 hours at 
room temperature. Finally the surface was washed with 5M sodium chloride solution 
for 24 hours, and then washed with the desired buffer. In FN adsorption pathway, the 
same procedures as above were used, except that no FN was added in the protein 
immobilization steps. After surface was blocked by the ethanolamine, FN was added 
into the system, reacted for 24 hours, and then washed with 5M sodium chloride for 










Figure 2 Scheme of FN immobilization on aminated PET surface. (a) FN conjugation 
pathway (b) FN adsorption pathway 
 
 
3.4.2 Chemical and physical characterization of the surface 
Immobilized FN quantification:  
2b) Wash 
3b) Block 
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The prepared surfaces were added to micro-BCA working solution (A: B: C: 
sodium carbonate buffer=25:24:1: 50), incubated at 37ºC for 2 hours. The total 
protein level was then measured by absorbance at 562nm.  
Surface contact angle measurements:  
Clean PET surface and FN immobilized PET surfaces were measured at room 
temperature and 60% relative humidity, using sessile drop method on a telescope 
goniometer. More than five measurements were carried out and the resulting values 
were averaged. 
XPS measurements: 
FN immobilized PET surfaces were measured by VG ESCALAB MkII 
spectrometer with a Mg Kα X-ray source (1253.6Ev photons) at a constant retard ratio 
of 40Ev. The PET films were mounted on the standard sample studs by means of 
double-sided adhesive tapes. The core-level signals were obtained at the 
photoelectron takeoff angle of 90º. A survey scan spectrum was taken and surface 
elemental stoichiometrics were determined from peak area rations.  
AFM measurements:  
The surface topography of FN conjugated PET, FN adsorbed PET was 
examined on a Nanoscope IIIa AFM (Digital Instruments Inc. USA.) in air. Atomic 
force microscope images were obtained by scanning surface in the tapping mode. The 
driven frequency was 330 ± 50 KHz. The applied voltage was between 3.0 and 4.0 V, 
and the drive amplitude was about 300Mv, scanning rate was 1.0 Hz. An arithmetic 
mean of the surface roughness profile was determined. 
 
3.4.3 Biological characterization of the surfaces 
ELISA 
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FN-immobilized PET surfaces were first captured by primary antibody, rabbit 
anti-human VCIP/RGD domain, (1:5000 dilution in BSA solution for 2 hours at 37ºC). 
After washing, the surfaces were bound by secondary antibody, goat anti-rabbit IgG 
conjugated with peroxidase (1:5000 dilutions in BSA solution for 2 hours at 37ºC). 
After washing off the unbound secondary antibody, Slow-TMB-solution was added to 
each well incubated for 5-30 min at room temperature in darkness, which was 
oxidized by peroxidase, showing the absorbance value at wavelength of 450nm. The 
ELISA results for active RGD domains were expressed as equivalent FN according to 
the linear FN adsorption isotherm on ethanolamine blocked PET surface as a function 
of total FN surface density (by micro-BCA).  
In vitro cell culture experiment 
The BHK21 cell line was maintained in RPMI 1640 medium supplemented 
with 10% fetal calf serum, penicillin (100U/ml), and streptomycin (10mg/ml). The 
cell studies were carried below passage 20. Before the cell assay on the surface, the 
BHK 21 cells were pretreated with serum-free medium for 2 hours, and then detached 
by incubation with non- enzyme cell dissociation solution, in order to avoid the serum 
effect and protect cell surface receptor from degradation.  
In cell viability assay, cells (seeding density 10,000 per well [96-well plate]) 
were cultured for 24 hours, and then measured by MTT test. In cell adhesion assay, 
cells (seeding density 200,000 per well [24-well plate]) were incubated for 2 hours. 
The unattached cells were washed by warmed PBS several times. The adherent cells 
were lysed by 4% SDS and centrifuged. The supernatant was subjected to BCA assay. 
Based on the assumption that the cells had equal amount of proteins, the total protein 
content quantified by BCA was correlated with cell numbers. As the FN surface 
density was very low, it would not affect the cell number determination.  
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3.5 Statistical analysis 
Data were presented as the mean ± SD. The statistical significance of the data 


























MSC AND CB34+ CELLS CO-CULTURE 
 
4.1 Screening of co-culture conditions 
The expansion of CB CD34+ cells for clinic application requires serum free 
condition. And as the CB cells are non adherent cells, the exchange of medium is not 
allowed during the expansion process, which will lead to the loss of cells and the 
increase the consumed cost of cytokines. In this project, we chose StemSpan serum 
free medium combined with 40ug/ml low density lipoprotein, 100ng/ml SCF, 
100ng/ml FL, 50ng/ml TPO, and 20ng/ml IL-3. Then we studied MSC metabolic level 
in this serum free medium, and optimized the co-culture conditions. 
 
4.1.1 MSC metabolic level in StemSpan medium 
Alamarblue was used as an assay to continuously test MSC metabolic level in 
MSCGM and StemSpan serum free medium, which were presented as Alamarblue 
reduction percentages. Figure 3 showed that after 10 days incubation in StemSpan 
serum free medium, MSC metabolic level (Alamarblue reduction percentages) 
decreased from 60.8±0.95% to 55.4±2.81%. It suggested that MSC could survive in 
this cord blood expansion condition, and maintain its basic metabolic level. Based on 
this result, we concluded that the CB expansion condition was applicable to MSC. 
 
4.1.2 Optimize expansion scale 
To optimized the expansion scale of CB CD34+ cells,  first of all, we 
compared the CB CD34+ cells expansion in different scales: 600 cells expansion in 
600ul medium per well of 24-well tissue culture plate and 100 cells expansion in 
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100ul medium per well of 96-well tissue culture plate. Figure 4 showed that the 
expansion in 24 well tissue culture plate resulted higher total cells and CD34+ cells 
expansion fold ( 342.2±22.3 fold increase of total cells, 9±0.7 fold increase of CD34+ 
cells) than the expansion in 96 well tissue culture plate (155.2±11.6 fold increase of 
total cells, 3.3±0.5 fold increase of CD34+ cells). In the following experiment, we 























Figure 3 MSC metabolic level in MSCGM medium or StemSpan serum free medium 
with cytokines.  25000 MSCs were seeded into each well of 24-well plate at 
day 0. After 4 days culture with MSCGM medium, MSCs reached the 
confluence, subjected to StemSpan serum free medium for another 10 days 
incubation. Cell metabolic level were evaluated by Alamarblue test at day 4 



































































Figure 4 CB CD34+ cells expansion in 96-well or 24-well tissue culture plates. 96-
well TCPS: each well 100 CB 34+ cells expanded in 100 ul medium. 24-
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well TCPS: each well 600 CB34+ cells expanded in 600 ul medium. (n=3, 




4.1.3 Co-culture over MSC feeder layer 
4.1.3.1 Irradiated and non irradiated feeder layer 
Usually feeder layers were irradiated before co-culture, in order to suppress 
feeder layer’s overgrowth and its competition with expanding cells. Considering the 
relatively low metabolic level of MSC in StemSpan medium, we hypothesized that 
irradiation was unnecessary in this experiment. We compared CD34+ cells expansion 
over the irradiated feeder layer and non irradiated feeder layer. The result (Figure 5) 
showed that no difference existed between these two kinds of feeder layers in total 
cells expansion fold, the non irradiated feeder layer even lead to higher CD34+ 
percentages (8.99±1.50 % to 5.97±0.31%) and higher CD34+ cells expansion fold 
(47.4±4.8 to 31.9±1.6) than irradiated feeder layer. So MSC feeder layers could be 
directly used for co-culture, and supported CB CD34+ cells expansion better than 









































































Figure 5 CB CD34+ cells expansion on irradiated or non irradiated MSC feeder 




4.1.3.2 Feeder layer exchanged and non exchanged co-culture  
Inspired by the above result that non irradiated MSC feeder layers supported 
higher expansion of CB CD34+ cells, we hypothesized that the higher metabolic level 
of MSC may support CB expansion better. We designed an experiment that at the 5th 
day of co-culture, the culture medium and expanded cells were all transferred to a 
freshly prepared MSC feeder layer, then continued the left 5 days of co-culture. The 
presence of freshly prepared MSC feeder layer in the mid of co-culture, could 
enhanced the average MSC metabolic level. But the expansion result (Figure 6 )was 
negative. The exchange of freshly prepared feeder layer lead to the decrease of total 
cells expansion fold and CD34+ cells expansion fold. The possible explanation might 
be the loss of the cells during transferring and metabolic competition from the freshly 










































































Figure 6 CB CD34+ cells expansion with or without exchange of MSC feeder layer 
in the middle of co-culture. (n=3, p<0.05 for total cells expansion fold and 
CD34+ cells expansion fold). 
 
 
4.1.4 Co-culture over MSC pellet 
During the high density incubation, MSCs can aggregate, forming stable pellet. 
Compared with the monolayer, pellet can accommodate more cells in the same 
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culturing surface. Here I tested if MSC pellets can support CB CD34+ cells expansion 
better than MSC feeder layer. The result showed that despite of twice amount of the 
MSCs in pellet co-culture, MSC pellet co-culture failed to produce significant 
difference compared with MSC feeder layer co-culture. We found that once the pellet 
adhered to the surface, MSCs tended to migrate from pellet to surface, forming new 
monolayer. This kind of unstable morphology probably affect the expansion result, 








































































Figure 7 CB CD34+ cells expansion on MSC feeder layer or adherent MSC pellet. 
(n=3) 
 
 A B  
Figure 8 MSC pellet morphology under phase contrast microscope (Magnification: 
100X). A: MSC pellet adhered to the surface after 24 hours incubation. B: 
after another 2 days co-culture, MSC pellet spread to the surrounding surface. 
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Summary: The screening experiments showed that MSC can survive in the 
serum free StemSpan medium supplemented with growth factors and LDL. MSC’s 
metabolic level affected the expansion result. Neither too low or too high metabolic 
level was favorable for CB CD34+ cells expansion. The aggregated conformation of 
MSCs did not show any significant effect to CB expansion. In conclusion, we set the 
optimal co-culture condition as non irradiated MSC feeder layers culturing in 24-well 
tissue culture plate.  
 
4.2 Study of the contact and non-contact  co-culture  
Most of the co-culture research focused on identifying MSC secreted factors 
in supporting HSC expansion. Here we focused on another aspect of the problem:  the 
effect of cell-cell contact in co-culture. We adopted a system for non-contact co-
culture (transwell co culture). In that system MSC feeder layers were separated from 
the CB cells by cell culture inserts, but the molecular signals and factors still could 
communicate through the porous membranes (pore size: 0.4um) of the cell culture 
inserts. So the only difference to normal feeder layer co-culture would be the block of 
the cell-cell contact.  
In this study, 600 CB CD34+ cells (CD34+CD45+%: 91%; CD34+CD38-
CD45+%: 16.4%) were cultured in the presence of the cytokines SCF, FL, TPO and  
IL-3 for 10 days either in direct contact with a confluent layer of MSCs or physically 
separated from the MSC layer by transwell culture. The expansion result showed the 
incorporation of MSC feeder layer in both conditions was beneficial for CD34+ cells 
expansion. When blocked the cell-cell contact between CB cells and MSCs, the non-
contact co-culture resulted 316.5±55.1, 21.1±3.7 fold increase in total cells, 
CD34+CD45+ cells respectively, as compared to 545.4±82.0, 47.9±5.2 fold increase 
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in contact co-culture system. The significant decrease of total cells expansion fold, 
CD34+ cells expansion fold in non-contact system suggested cell-cell contact must 
play a crucial role in supporting CB cells expansion. Due to the system error in 
analysis CD34+CD38-CD45+ cells (another combination of markers to identify HSC), 
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Figure 9 CB CD34+ cells expansion in contact co-culture or non-contact co-culture. 







































Figure 10 Cell-cell contact study by CMFDA and CD34 expression. A: Percentage of 
CMFDA stained cells. B: CD34+ expression over CMFDA+ cells and 
CMFDA- cells in contact co-culture and non-contact co-culture system. 
(n=4). 
Then we tried to quantify this kind of cell-cell contact, and its direct result to 
CD34 surface markers expression. We used long term tracing staining- CMFDA 
stained MSC feeder layer first, then co-culturing CB cells for 10 days. If there was 
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cell-cell communication between MSCs and CB cells, CMFDA would be transferred 
to the interacted CB cells through plasma exchanges. The non-contact co-culture was 
used as a control, to test if there was CMFDA diffusion existed between non-contact 
cells. The result (Figure 10)showed that about 1. 65±0.55 % expanded cells were 
stained with CMFDA in contact co-culture system, while nearly no expanded cells 
stained with CMFDA in non-contact system. 63.9±17.4% of the CMFDA+ cells 
expressed CD34, which was about 8 times higher than the CMFDA- cells in contact 
co-culture. This highly suggested that cell-cell communication existed between MSCs 
and CB cells in contact co-culture, and that kind of cell-cell communication helped to 
reserve stem cell primitivity. 
 
4. 3 Function assays of contact and non-contact co-culture 
4.3.1 Phenotype screening of the expanded cells I 
To investigate the differentiation status of the expanded cells, we analyzed the 
surface markers expression on the expanded cells by flow cytometry. The 
incorporation of MSC in both systems displayed similar phenotypic surface markers 
expression profile in increasing CD34+CD45+ cells %, CD38+CD45+ cells %, 
CD19+cells % and decreasing Gly-A+ cells % compared to the TCPS control and 
transwell control. These results suggest that the MSC incorporated co-cultures 
favored the expansion of primitive cells (CD34) and lymphocytes (CD38), in 
particular B-lymphoid cells (CD19) and slowed down erythrocyte (Gly-A) 
differentiation. On the other hand, when contact co-culture and non-contact co-culture 
systems were compared, direct cell-cell contact resulted in the increase of 
CD34+CD45+ %, CD45+ cells %, CD38+CD45+ cells  %, CD15+CD45+ cells % 
and the decrease of Gly-A+ cells %, CD3+ cells %,  CD19+ cells %, but there was no 
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significant difference in CD34+CD38-CD45+ cells % and CD41+ cells %. The results 
suggested that direct cell-cell contact favored monocytes / granucytes (CD15) 
differentiation, slowed down erythrocyte (Gly-A), B-lymphoid cells (CD19), T-
lymphoid cells (CD3) differentiation, and maintained slightly higher percentages of 
more primitive cells, compared with non-contact co-culture. 
In control experiments, we investigated whether the doubling the volume of 
culture medium in the non-contact system could affect the expansion of CB CD34+ 
cells. No significant differences in terms of cell expansion and cell phenotype were 
observed when compared to cultures without MSC (data not shown). This confirmed 
that the medium volume was not confounding factor.  
Table 1: Surface markers expression of expanded cells I: 
 
Percentage % CD45+ CD34+CD45+ CD34+CD38-CD45+ CD38+CD45+ 
Contact co-culture 85.87±5.85* 8.22±1.12 3.15±1.73 29.37±6.24* 
TCPS control 71.45±8.45 3.42±1.01 2.00±0.75 10.56±2.07 
Non-contact co-
culture 73.22±4.02 6.14±0.78 2.77±1.98 14.23±2.38 
Transwell control 69.05±18.27 2.74±0.67 1.98±0.83 7.83±1.91 
 
Percentage % CD15+CD45+ Gly-A+ CD3+ CD19+ CD41+ 
Contact co-
culture 43.27±8.87* 20.99±5.84* 0.30±0.07* 1.08±0.33* 5.83±1.74 
TCPS control 27.36±5.32 30.56±3.25 0.44±0.15 0.41±0.11 4.19±1.48 
Non-contact co-
culture 25.43±0.23 28.51±0.41 1.06±0.35 3.39±1.64 6.06±2.52 
Transwell control 25.74±2.83 44.8±9.91 0.91±0.10 0.40±0.09 2.44±0.50 
CD15: Monocytes and Granulocytes; Gly-A: precursors of Erythrocytes, CD3+: T 
cells, CD19+: B cells, CD41+: Megakaryocytes, the precursor of plateles. (n>6 for the 




4.3.2 CFC I 
The CFC assay evaluates the multipotency of the cells following expansion. 
Figure 11 shows the colony counts derived from the expanded cells, expressed as fold 
increase over the number of colonies derived from 600 freshly thawed CB CD34+ 
cells (total CFC colonies: 132.8 ±8.5; CFC-GM: 72±3.2; CFC-E: 20±3.5; CFC-
GEMM: 40.8±8.7). The contact co-culture produced higher fold increase in CFC-GM 
colonies and total CFC colonies, which were consistent with the expansion and 
phenotype screening result. In terms of CFC profile (Figure 11B) ex vivo expansion 
appear to have induced an increase of CFC-E at the expense of CFC-GEMM in 















































Figure 11 CFC properties of expanded cells I. 600 CB CD34+ enriched cells (CFC-
GM: 72±3.17; CFC-E: 20±3.46; CFC-GEMM: 40.8±8.65) were expanded 
in contact or non-contact system with or without MSC. A: Colonies fold 
increase. B: Colonies distribution. (Mean + SD; n>4; *p<0.05 compared 
with 2D co culture)  
 
4.3.3 Animal engraftment I 
The Repopulation assay of human hematopoietic stem cell in NOD/SCID 
mouse can quantitatively measure the dual ability of stem cells to self-renew and 
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differentiate. From the literature, the lowest number of CD34+ CB cells that can 
engraft NOD/ SCID mice is around 2×104 [Holyoake et al (1999)].  
Table 2: The engraftment and lineage expression by human cells in the bone marrow 
of NOD/SCID mice I 
Human Cells (%) 
Mouse injection Positive Mice * CD45+ CD41+ CD19+CD45+ CD13+CD45+ GlyA+ 
20000 uncultured 
CD34+ CB cells 3/3 
0.232; 
10.094; 1.132 0.723±0.01 3.056±4.36 0.672±0.74 3.476±0.26
600 uncultured 
CD34+ CB cells 3/3 
2.386; 
0.248; 0.739 -0.106±0.3 0.532±0.55 0.606±0.83 1.521±1.60
Injected cells were expanded from 600 CD34+ CB cells in the following systems:  








1.246; 0.589 0.193±0.1 0.86±0.24 0.981±0.32 2.245±0.51
Control (Tissue 
culture plates) 4/7 
0.013; 0.603; 
0.487; 1.045; 
1.379; 0; 0 
0.732±0.4 0.667±0.28 1.082±0.70 3.767±0.58
*Positive mice were identified by at least 0.2% of human CD45+ cells of total lysed 
bone marrow cells. The lineage expression of human megakaryocytes CD41+; human 
B cells CD19+CD45+; human monocytes and granulocytes CD13+CD45+; human 
erythrocytes Gly-A were studied by FACS in all the positive mice.  
The ex vivo results suggested that the co-culture produced about 550-320 fold 
increase of CD34+CD45+ cells, 50-100 fold increase of CD34+CD38-CD45+ cells and 
80-90 fold increase of CFC-GEMM colonies. Based on this reasoning, cells expanded 
from about 600 initial CD34+ CB cells would be expected to contain enough 
progenitors to reconstitute the hematopoiesis of irradiated NOD/SCID mice. As no 
significant difference in expansion results was observed among all the non co-culture 
systems, we chose cells expanded from the 2D control (TCPS) as a common control 
for all the non co-culture systems. In addition, un-expanded CD34+ CB cells at two 
different doses (600 and 20,000 cells) were also transplanted for comparison. Table 2 
show the engraftment efficiency of the expanded cells as well as their differentiation 
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potential in the positive mice. The contact co-culture system produced an engraftment 
percentage above 1%, which were better than non-contact co-culture system and 
TCPS control. The engraftment of the unexpanded cells, particularly at low dose, was 
unexpected. Nevertheless, there is high variability among animals in these two groups. 
The results highlight the fact that ex vivo expansion would impair stem cells 
transplantation ability.  
 
4.4 Discussion 
Hematopoietic stem cells, defined by their ability to self-renew and to 
differentiate into all mature blood cell types, have by far been the most widely applied 
stem cells in the clinic for treatment of such diseases as leukemias and other 
malignant cancers as well as several non-malignant blood disorders. However, the 
clinical applications of HSC are severely hampered by our limited understanding of 
the mechanisms that control HSC self-renewal and differentiation and by the inability 
to expand HSC in culture.  However, over the past 15 years, rapid advances have been 
made in the understanding of HSC biology, particularly in the roles of cytokines and 
signaling molecules such as Wnt, Notch etc [Zhang et al (2003); Calvi et al (2003)]. 
These findings have led to the development of stroma-free ex vivo expansion systems, 
which are clinically more well-defined and accepted [Lazzari et al (2001)]. Recently 
however, interest has been revived in stroma-supported culture systems and various 
cell types including several primary cell types [Breems et al (1998)], immortalized 
stroma cell lines [Nishioka et al (2003)], or genetically engineered cytokine-secreting 
cells [Balduini et al (1998)]. Feeder cultures are able to provide a more 
physiologically relevant repertoire of factors that promotes HSC self-renewal and 
maintenance.  
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MSC is a non hematopoietic, well-characterized homogeneous population of 
adherent skeletal and connective tissue progenitor cells within the bone marrow 
stroma [Haynesworth et al (1992); Majumdar et al (1998); Pittenger et al (1999)]. It is 
one of the most promising stem cell types due to their availability and the relatively 
simple requirements for ex vivo expansion. Importantly, MSC provides a rich 
environment of signals, including cytokines, ECM proteins, adhesion molecules, and 
cell-cell interactions, controlling the proliferation, survival, and differentiation of 
early lympho- hematopoietic stem cells [Haynesworth et al (1996), Majumdar et al 
(2000)]. Accordingly, MSC has been shown to be capable of supporting HSC 
expansion ex vivo [Kadereit et al (2002); Wang et al (2004); McNiece et al (2004)]. 
Similar to Dexter-type stroma cells, MSC can also support LTC-IC colonies during 
prolonged ex vivo bone marrow culture [Majumdar et al (2000)]. 
In addition to the abovementioned advantages, MSC, like other stem cells 
which are poor antigen presenting cells, are relatively immunologically compatible, 
and show positive augmentative role in HSC transplantation. High dose chemotherapy 
or total body irradiation often results in the ablation of the bone marrow stroma, 
which is critical for the maintenance of hematopoiesis. Previous animal studies 
suggest that the transplantation of healthy stroma components including MSC 
enhances the ability of the bone marrow micro environment to support hematopoiesis 
following transplantation [Devine et al (2001)]. Recent studies have shown that 
autologous MSC expanded ex vivo could accelerate hematopoietic recovery after 
HSC transplantation [Koc et al (2000); Westerman and Leboulch (1996)]. Allogeneic 
MSC expanded in culture has been successfully co-infused with T-cell depleted 
peripheral blood hematopoietic progenitors into a haploidentical receipient and is 
currently under further clinical evaluation [Lee et al (2002)]. In summary, all these 
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studies have shown that MSC is a good stroma candidate. We therefore incorporated 
it into our CB expansion systems.  
Most of the studies which focus on the secretion effect of MSC showed that 
MSC secretes, at baseline, IL-6, IL-7, IL-8, IL-11, IL-12, IL-14, and IL-15, MCSF, FL, 
and SCF, similar to the cytokines and growth factors expressed by marrow derived 
stroma cells [Majumdar et al (1998)]. We wondered whether conditioned medium 
could replace the total function of MSC ex vivo, or is the cell-cell contact needed. We 
adopted the transwell co-culture system, which blocks the cell-cell contact, but still 
permits the molecular signal exchange through porous membrane. Our results 
indicated that the contact co-culture increased the expansion of total cells (545.4 
vs.316.5 fold), CD34+ cells (47.9 vs. 21.1 fold), CD34+CD38- cells (100.4 vs. 52.8 
fold) compared with the non-contact co-culture in transwell system. Similarly, the 
pluripotency of cells expanded in contact co-culture as evaluated by CFC assay was 
also superior compared to those expanded in non-contact co-culture (CFU-GEMM: 
84.1 vs. 76.0 fold; total CFU 150.1 vs. 116.5 fold). The animal engraftment assays 
also showed that cells expanded in contact co-culture system appeared to be more 
competent in reconstructing short term hematopoiesis. The CMFDA staining showed 
that the 63.9% of the anchored cells to the stroma layer (CMFDA+), expressed CD34 
surface marker, which is about 8 times higher than suspension cells. The findings 
suggested that contact co-culture is effective in maintaining stem cell function, 







MSC AND CB CD34+ CELLS 3D CO-CULTURE  
 
5.1 Screening of 3D scaffolds 
In this study we incorporated MSC stroma into the 3D system supporting CB 
CD34+ cells expansion, in order to more faithfully replicating the in vivo 3D marrow 
configuration.  
A  B  
C  D  
Figure 12 SEM image of PET meshes and co-culture in meshes. A: PET unwoven 
mesh; B: CB and MSC co-culture over PET unwoven mesh (Day 10 ). C: 
PET woven mesh; B: CB and MSC co-culture over PET woven mesh (Day 
10 ). 
First of all we screened two commonly used 3D systems: unwoven PET mesh 
and woven PET mesh. Although serum coated unwoven PET mesh achieved good 
expansion result in the literature, the MSC co-culture in non woven PET fibrous 
matrices induced quite limited expansion of CD34+ cells. It was probably because of 
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the space limit in structure for co-culture (expanded MSC size: about 20*60 um, CB 
cells diameter 3-10 um, compared to the controlled pore size 10-60 um in fibrous 
matrices), and difficulties in harvesting the entrapped CB expanded cells from the MSC 
stroma in the scaffold. For the application purpose we gave up this scaffold, chose 
woven PET mesh, which was relatively easy to isolate cells, while still maintaining part 
of the 3D structure. The PET woven mesh comprises of fibers (mesh opening 1um, wire 
diameter 34 um, thickness 70 um, and 6.29 fold increase of surface area compared to 



















































































Figure 13 CB CD34+ cells expansion in PET woven or unwoven mesh. (n=4, p<0.05 
compare woven mesh co-culture with the other groups). 
 
5.2 Study of 3D and 2D co-culture 
In this study, 600 CB CD34+ cells (CD34+CD45+%: 91%; CD34+CD38-
CD45+%: 16.4%) were cultured in the presence of the cytokines SCF, FL, TPO and  
IL-3 for 10 days in direct contact with a confluent layer of MSC growing on 2D or 3D 
scaffolds. As shown in Figure 14, the expansion of total cells, CD34+CD45+ cells and 
CD34+CD38-CD45+ cells in 3D co-culture were all significantly higher than those of 
the other groups. Co-culture in 3D configuration resulted in approximately 
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891.2±163.6, 96.0±20.2, 273.2±106.1 fold increase in total cells, CD34+CD45+, and 
CD34+CD38-CD45+ cells, respectively, as compared to 545.4±82.0, 47.9±5.2, 
100.4±51.7 fold increase in the 2D co-culture system. These results also suggest that 










































































Figure 14 CB CD34+ cells expansion in 2D or 3D systems. (n>10, p<0.05 compare 
woven mesh co-culture with the other groups). 
 
5.3 Functional assays of 3D and 2D co-culture  
5.3.1 Phenotype screening of expanded cells II 
To investigate the differentiation status of the expanded cells, we analyzed the 
surface markers expression on the expanded cells by flow cytometry. Cells expanded 
in the 2D and 3D co-cultures displayed very similar phenotypic surface marker 
expression profiles. The notable exceptions are the increase in the CD34+CD38-
CD45+ (5.08% vs. 3.15%; p: 0.019) and CD19+ (2.94% vs. 1.08%; p: 0.041) 
populations in the 3D co-culture systems (Table 3). In comparison to the TCPS 
controls, the co-cultures in 2D and 3D systems showed increases in CD45+, 
CD34+CD45+, CD38+CD45+ and CD19+ cell population but a decrease in Gly-A+ 
cell population, There is however no significant difference in the CD15+CD45+, 
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CD3+%, and CD41+ populations after expansion. These results suggest that the 
contact co-cultures favored the expansion of primitive cells (CD34) and lymphocytes 
(CD38), in particular B-lymphoid cells (CD19). It also resulted in a reduction in 
erythrocyte (Gly-A) population, and produced no significant effects on the 
percentages of monocytes/granulocytes (CD15), T cells (CD3), and megakaryocytes 
(CD41). 
Table 3 Surface markers expression of expanded cells II 
 
Percentage % CD45+ CD34+CD45+ CD34+CD38-CD45+ CD38+CD45+ 
2D co-culture 85.87±5.85 8.22±1.12 3.15±1.73 29.37±6.24 
TCPS control 71.45±8.45 3.42±1.01 2.00±0.75 10.56±2.07 
3D co-culture 85.54±3.77 10.06±2.63 5.08±1.83 26.71±5.39 
3D control 61.51±15.44 2.82±0.69 1.80±0.76 8.32±4.32 
 
Percentage % CD15+CD45+ Gly-A+ CD3+ CD19+ CD41+ 
2D co-culture 43.27±8.87 20.99±5.84 0.30±0.07 1.08±0.33 5.83±1.74 
TCPS control 27.36±5.32 30.56±3.25 0.44±0.15 0.41±0.11 4.19±1.48 
3D co-culture 37.01±5.68 21.01±2.45 0.99±0.64 2.94±0.87 4.96±1.41 
3D control 27.39±6.33 47.77±11.57 0.43±0.10 0.19±0.19 2.34±0.20 
CD15: Monocytes and Granulocytes; Gly-A: precursors of Erythrocytes, CD3+: T 
cells, CD19+: B cells, CD41+: Megakaryocytes, the precursor of platelets. *p<0.05 
compared to its internal control: cytokine expansion only. (n>6 for the first 4 
categories, n>3 for the left categories)  
In control experiments, we investigated whether the presence of 3D PET mesh 
alone could affect the expansion of CB CD34+ cells. No significant differences in 
terms of cell expansion and cell phenotype were observed when compared to cultures 
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without MSC (data not shown). This confirmed that the PET mesh was not 
confounding factor. 
 
5.3.2 CFC II 
The CFC assay evaluates the multipotency of the cells following expansion. 
Figure 15A shows the colony counts derived from the expanded cells, expressed as 
fold increase over the number of colonies derived from 600 freshly thawed CB 
CD34+ cells (total CFC colonies: 132.8 ±8.5; CFC-GM: 72±3.2; CFC-E: 20±3.5; 
CFC-GEMM: 40.8±8.7). The 3D co-culture produced the highest fold increase across 
all CFU types assessed, being statistically significant from the 2D co-culture. The 
trend is consistent with the cell expansion result. In terms of CFC profile (Figure 15B), 
ex vivo expansion appear to have induced an increase of CFC-E at the expense of 
CFC-GEMM in comparison with unexpanded cells. No significant effect on the CFC-
GM% was observed.  The 3D co-culture showed a higher CFC-GEMM% than the 2D 
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Figure 15 CFC properties of expanded cells II. 600 CB CD34+ enriched cells (CFC-
GM: 72±3.17; CFC-E: 20±3.46; CFC-GEMM: 40.8±8.65) were expanded 
in 2D or 3D system with or without MSC. A: Colonies fold increase. B: 
Colonies distribution. (Mean + SD; n>4; *p<0.05 compared with 2D co 
culture)  
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5.3.3 Animal engraftment II 
The repopulation assay of human hematopoietic stem cell in NOD/SCID 
mouse can quantitatively measure the dual ability of stem cell to self-renew and 
differentiate. From the literature, the lowest number of CD34+ CBcell that can engraft 
NOD/ SCID mice is around 2×104 [Holyoake et al (1999)]. The ex vivo results 
suggested that the co-culture produced about 50-100 fold increase of CD34+CD45+ 
cells, 100-270 fold increase of CD34+CD38-CD45+ cells and 80-180 fold increase of 
CFC-GEMM colonies. Based on this reasoning, cells expanded from about 600 initial 
HSC would be expected to contain enough progenitors to reconstitute the 
hematopoiesis of irradiated NOD/SCID mice. As no significant difference in 
expansion results was observed among all the non co-culture systems, we chose cells 
expanded from the 2D control (TCPS) as a common control for all the non co-culture 
systems. In addition, un-expanded CD34+ CB cells at two different doses (600 and 
20,000 cells) were also transplanted for comparison.  
Table 4 showed the engraftment efficiency of the expanded cells as well as 
their differentiation potential in the positive mice. The 3D co-culture system 
consistently generated engraftment of human CD45+ cells at percentages above 1.5% 
in all mice analyzed. Similarly, the 2D co-culture system produced an engraftment 
percentage above 1%. The difference between these two systems is statistically 
significant (p3D co to 2D co=0.008). Cells expanded in 3D co-culture also yielded higher 
human B cells (CD19+CD45+) and monocytes and granunolocytes (CD13+CD45+) 
engraftment percentages (B cells: P3D co to 2D co=0.035; monocytes and granulocytes: 
P3D co to 2D co=0.008). This result was consistent with the observed higher CD34+ and 
CFC-GEMM expansion results. The engraftment of the unexpanded cells, particularly 
at low dose, was unexpected. Nevertheless, there is high variability among animals in 
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these two groups. The results highlight the fact that ex vivo expansion would impair 
stem cells transplantation ability.    
Table 4 The engraftment and lineage expression by human cells in the bone marrow 
of NOD/SCID mice II 
Human Cells (%) 
Mouse injection Positive Mice * CD45+ CD41+ CD19+CD45+ CD13+CD45+ GlyA+ 
20000 uncultured 
CD34+ CB cells 3/3 
0.232; 
10.094; 1.132 0.723±0.01 3.056±4.36 0.672±0.73 3.476±0.26
600 uncultured 
CD34+ CB cells 3/3 
2.386; 
0.248; 0.739  -0.106±0.32 0.532±0.55 0.606±0.83 1.521±1.61
Injected cells were expanded from 600 CD34+ CB cells in the following systems:  




1.77±0.99 2.125±0.68 3.008±0.85 6.178±2.25




0.664±0.86 1.193±0.41 1.268±0.35 3.972±1.06
Control (Tissue 
culture plates) 4/7 
0.013; 0.603; 
0.487; 1.045; 
1.379; 0; 0 
0.732±0.43 0.667±0.28 1.082±0.70 3.767±0.58
*Positive mice were identified by at least 0.2% of human CD45+ cells of total lysed 
bone marrow cells. The lineage expression of human megakaryocytes CD41+; human 
B cells CD19+CD45+; human monocytes and granulocytes CD13+CD45+; human 
erythrocytes Gly-A were studied by FACS in all the positive mice. (Mean ± SD; 
*p<0.05 compared with other expanded cells engraftment). 
 
5.4 3D culture of MSC 
In an attempt to understand the observed differences in the supportive role of 
MSC in the 2D and 3D co-culture systems, we analyzed the attachment, proliferation 
and ECM production of the cells cultured on the PET woven fabric and TCPS. The 
result (Figure 16) showed that the 3D PET woven structure was more favorable for 
cell attachment, or possibly entrapment (77.4±3.3% vs. 60.8±4.5%). Consequently, 
the 3D system maintained more cells in confluence compared with the 2D system 
(65,000 ± 5,000 cells per well vs. 52,000 ± 2,000 cells per well at day 4). MSCs 
grown in the PET mesh also showed higher protein production compared to those 
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grown on TCPS. (7.3±0.6 vs. 6.2±1.7 ug per 10000 cells; p: 0.0157). Scanning 
electron microscopy revealed that the MSCs grown on the PET mesh secreted copious 
amount of ECM proteins that were organized into an extensive fibrous network 
(Figure 17). In contrast, MSCs grown on TCPS displayed relatively sparse ECM 
production. The immuno-staining showed that MSCs exhibited a more elongated 
morphology in PET mesh than in TCPS surface. Cultured on TCPS, the MSCs 
expressed FN but not collagens I, collagen IV, and laminin. Cultured on the PET 
mesh, the MSCs expressed FN strongly and also detectable although low amount of 

































































Figure 16 MSC attachment, proliferation, and protein production in 2D or 3D 
systems. A: MSC attachment on 3D PET mesh and 2D TCPS after 24 
hours incubation. B: MSC proliferation after 4 days culture on 3D PET 
mesh and 2D TCPS. C: Protein production per 10,000 cells after 4 days 
culture on 3D PET mesh and 2D TCPS. (Mean ± SD, n=4; Pattachment: 
0.0009; Pcell number:0.002; Pprotein production: 0.0157). 
 
5.5 Discussion 
Recently, the function of 3D micro environment in hematopoiesis has attracted 
more attention and interests. Quite a few 3D systems were designed to enhance cell–
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cell and cell–matrix interactions, in an effort to mimic the in vivo 3D bone marrow 
structure in which more than 95% of normal hematopoiesis occurs; like collagen 
coated nylon mesh [Naughton et al (1987) Naughton et al (1990)], porous collagen 
micro spheres [Wang et al (1995); Mantalaris et al (1998)], tantalunm coated cellfoam 
[Rosenzweig et al (1997)],  serum coated unwoven PET fibrous matrices [Li et al 
(2001)] in supporting CB or bone marrow cells expansion.  
 
Figure 17 SEM and Confocal images of MSCs culture and co-culture in 2D or 3D 
systems. A-B: MSCs grown on 3D and 2D surface at confluence; C: MSCs 
and CB cells after 10 days co-culture; D-E: MSCs grown on 3D and 2D 
surface; F-G: Fibronectin expression in 3D and 2D culture; H-I: Collagen I 
expression in 3D and 2D culture. Cells were stained with CMFDA (green); 
each kind of ECM proteins was stained with TRITC (red) separately. 
In this study, we investigated the effects of a combination of MSC feeder layer 
with 3D architecture on CB CD34+ cells expansion. MSCs were cultured on woven 
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PET mesh (mesh opening 1um, wire diameter 34um, thickness 70um, and 6.29 fold 
increase of surface area compared to the 2D surface, detected by micro CT). Our 
results indicated that co-culture of CB CD34+ cells with MSCs in a 3D setting 
produced increased expansion of total cells (891.2- vs 545.4-fold), CD34+ cells (96.0- 
vs 47.9-fold) or CD34+CD38- cells (273.2- vs 100.4-fold) compared to control 
culture.  Similarly, the pluripotency of cells expanded on 3D co-cultures as assessed 
by CFU assay was also superior compared to those expanded on 2D coculture (CFU-
GEMM:183.6- vs  84.1-fold; total CFU: 229.9- vs 150.1-fold). Additionally, animal 
engraftment assays have shown that cells expanded in the 3D co-culture appear to be 
more competent in reconstituting short term hematopoiesis. Cytochemical staining 
revealed that culture of MSCs on 3D mesh led to increased proliferation which may 
contribute to the increase in beneficial effects on CB expansion. More importantly, we 
observed high expression of ECM fibrils on MSCs grown in 3D culture, a feature not 
seen for cells grown on 2D culture. This result is consistent with the former findings 
[Grayson et al (2004)] which showed that MSCs secreted more ECM protein such as 
FN when cultured in 3D non-woven PET matrices. Scanning electron microscopy 
reveals a tendency of hematopoietic cells to aggregate in crevasses formed by fibrils 
and cell structures. This may provide 3D topological cues necessary to maintain the 
primitiveness and pluripotency of the CD34+ cells. 
In addition to providing mechanical support , the endogenous bone marrow 
furnishes a biochemical environment by secreting a complex meshwork of ECM rich 
in proteins such as collagen and elastin, specialized proteins such as FN and laminin, 
and proteglycans, It has been reported that ECM glycosaminoglycan side chains can 
bind soluble growth factors forming concentration gradients that among other roles 
aid in cell anchorage, facilitate receptors dimerization and signal transduction, 
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modulate extra cellular proteolysis and protect signal molecules from being degraded 
[Ramirez and Rifkinb (2003) ]. Cell adhesion motifs present in the ECM also play 
important roles in the regulation of stem cell biology.  FN which is secreted by bone 
marrow stroma cells, have been found to have important influence on HSC cell cycle. 
Its receptors, integrin α4β1 and α5β1, are highly expressed on HSC.  This implied 
that besides its traditional functions in HSC lodgment, FN may also take part in the 
maintenance of the self-renewal ability of HSC within the hematopoietic niche. 
Evidence comes from studies that showed that adhesion to FN during ex vivo culture 
preserves the regenerative capacity of human PHPCs/HSCs [Dao et al (1998)].  Taken 
together, we postulate that the influence of a 3D microenviroment coupled with 
elevated deposition of ECM by MSC create a cellular niche more closely resembling 




















STUDY OF FN IMMOBILIZATION BIOACTIVITY 
 
Inspired by the 3D co-culture results that FN was specially secreted by MSCs 
in the co-culture system and FN’s potential functions in controlling cells adherence 
and cell cycles, we hypothesized that FN may play a very important role in CB’s 
expansion. Immobilization of FN onto the surface of culture system may represent a 
stroma free expansion strategy. The purpose of this sub project was to evaluate two 
common protein immobilization methods, and study the change of FN bioactivity 
during the immobilization process. The results of this study would be applied to 
construct artificial HSC expansion niche in the future. 
 
6.1 Physical and chemical characterization of conjugated and adsorbed FN 
6.1.1 FN immobilization efficiency 
The amount of the immobilized FN on modified PET surface was determined 
by the micro BCA assay, which depends on the number of peptide bonds and the 
presence of four amino acids (cysteine, cystine, tryptophan and tyrosine). Figure 18 
shows the surface density of FN as a function of the input concentration in solution. 
The conjugation method produced a higher FN content onto the surface than the 
adsorption method. With adsorption, the content of FN adsorbed reached a saturation 
level around 400 ng/cm2 once the FN input concentration exceeded 4 ug/ml. The 
saturation level is consistent with conventional adsorption isotherms, representing 
approximately the amount of FN necessary to produce a monolayer coating based on 
the dimension of the molecules [Williams et al (1982)]. In contrast, the conjugation 
method seemed to be able to form multiple layers of FN despite extensive washing. 
At an FN input concentration of 30 ug/ml, 918±134 ng/cm2 of FN could be stably 
immobilized onto the surface. 
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6.1.2 XPS assay 
XPS instruments measure the number and kinetic energy of emitted 
photoelectrons. Because the core electrons of each element have characteristic 
binding energies, the peaks in the XPS spectra allow identification of all elements, 
except H and He. Among the elements detected, the N1s signal percentage as a 
function of the FN surface density was shown for both substrates in Figure 19 and 
Table 5. The XPS data showed that FN covalent conjugated surface had higher 
nitrogen percentages. This result was consistent with the micro-BCA result, that more 








0 3 6 9 12 15 18 21 24 27 30



















Figure 18  FN immobilization efficiency. FN surface density (by micro-BCA assay) 
was immobilization methods (conjugation & adsorption) and protein 
concentration (0.256ug/ml-30ug/ml) dependent. Mean ± SD was obtained 




















































Figure 19  XPS survey of FN immobilized PET surface. A) Clean PET surface; B) Fn 
conjugated surface; C) Fn adsorbed surface                                 
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Table 5 Element proportion on FN immobilized surface  
Element Percentages  
Surface 
C  O  N  
Fn conjugated PET 67.4 26.47 6.13 
Fn adsorbed PET  70.07 24.14 5.79 
  
6.1.3 Surface contact angle measurements 
The contact angle between water and a surface is an inverse measure of the 
ability of water to ‘‘wet’’ the surface. A smaller contact angle indicates a hydrophilic 
surface, on which water spreads to a greater extent; a larger contact angle indicates a 
hydrophobic surface, on which water beads up.  
The cleaned and unmodified PET surface showed a static contact angle of 
74.1º ± 2.6º. Amination of PET surface with ethylenediamine lower the contact angle 
to 62.9º ± 3.1º by introducing the more polar amino groups on the surface. The 
conjugation of FN on aminated surface decreased the angle further to 56.7º ± 2.0º). 
The ethanolamine blocked surface had similar contact angle with the aminated surface 
(61.5º ± 2.9º), and the FN adsorption onto this surface did not change the contact 
angle further (61.8º± 2.1º). While the mechanism is not clear, the difference in the 
contact angles between the FN- conjugated and the FN-adsorbed surfaces (p<0.05) 
suggest dissimilarity in the conformation of FN presented on the surface.  
 
6.1.4 AFM assay 
In AFM assay, a sharp tip attached to a cantilever scanned across a surface. 
Changes in surface topography that were encountered as the tip moved over the 
material’s surface changed inter atomic attractive or repulsive forces between the 
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surface and tip. These forces were sensed and recorded to construct images of surface 






























Figure 20 Surface contact angle on clean, modified or FN immobilized PET surface 
(n>5). (p<0.05. between Fn conjugated PET and Fn adsorbed PET) 
A) B)                                
Figure 21 AFM image of FN immobilized PET surface. (A) FN conjugated PET 
surface, scanning area: 4.8um*4.8um. Ra: 119 nm, Rmax: 522 nm. (B) FN 
adsorbed PET surface, scanning area: 10um*10um Ra: 11.2nm, Rmax: 
217nm. 
Different morphology was observed when FN was conjugated or adsorbed to 
the PET surfaces in the AFM topographic images (Figure 21). On the FN-adsorbed 
PET surface, the protein appeared evenly distributed, with a mean roughness of 
Ra=11.2 nm and a maximal roughness of 217 nm. In contrast, the protein on the FN-
conjugated PET surface was more closely packed in layers, with a mean roughness of 
Ra=119 nm and a maximal roughness of 522 nm. Due to this kind of aggregation, the 
FN conjugated surface maintained higher FN density. Neither of the modification 
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processes changed surface area significantly (scanning area: 1um2, conjugation: 
1.06um2, adsorption: 1.13 um2).   
 
6.2 Biological characterization of conjugated and adsorbed FN 
6.2.1 ELISA test for RGD domain  
Although the FN surface density was higher in the FN-conjugated surface 
according to the micro-BCA result, the ELISA test for active RGD domains showed 
that FN bioactivity in the access to active RGD was lower in FN conjugated surface. 





















Figure 22 ELISA measurement of active RGD domains in immobilized FN compared 
with Micro –BCA result. (FN input concentration of 30ng/ml: conjugated 
FN surface density: 917.6±133.8 ng/cm2; adsorbed FN surface density: 
433.1±45.8 ng/cm2 by micro-BCA) Significant difference existed between 
two methods *p<0.05 (n>4). 
There was little difference between the micro-BCA and ELISA measurements 
for the surface density of adsorbed FN, 433.1±45.8 ng/cm2 versus 410.8±13.7 ng/cm2, 
respectively, at the FN input concentration of 30ug/ml. In contrast, the corresponding 
values for the conjugation method were 917.6±133.8 ng/cm2 and 220.3 ± 10.1 ng/cm2, 
which indicated a loss of 76% of the active RGD domains. 
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6.2.2 Ex vivo cell experiment 
To further assess the bioactivity of FN adsorbed surface and FN conjugated 
surface, we compared the measured cell behaviors as a function of surface. The cells 
viability over 24 hours on the two FN-immobilized PET surfaces did not show any 
significant difference according to the MTT assay. However, the adhesion of BHK21 
cells at the 2 hours time point was quite different (Figure 23). The FN-adsorbed PET 
surface supported cell adhesion (from 53.6±10.2% to 70.3±9.4%) with the increase of 
adsorbed FN surface density (from 0 to 433.1±45.8 ng/cm2). The FN-conjugated 
surface on the other hand suppressed cell adhesion (from 53.6±10.2% to 12.2±6.0%) 
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Figure 23 Cell adhesion on FN immobilized PET surface (n>4) 
 
6.3 Discussion 
6.3.1 FN conformation and its bioactivity 
Many studies have shown that the conformation flexibility influences the 
biological properties of FN. Certain activities of FN are latent in the intact molecule 
and become fully expressed in its proteolytic fragments [Muir and Manthorpe (1992)]. 
For example, 29 and 40 kDa heparin-binding proteolytic fragments of FN are potent 
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inhibitors of endothelial growth ex vivo, while native FN is not [Homandberg et al 
(1985)]. Generally it is believed that FN molecules is secreted by cells and folded into 
globular domains specialized for particular functions, such as binding to integrins, 
collagen, heparin sulfate, hyaluronic acid, the change of their conformation would 
affect their bioactivity. [Morla and Ruoslahti (1992)] 
 
6.3.2 FN adsorption 
Langmuir isotherm was often used for the rudimentary description of protein 
adsorption phenomena: the near-linear dependence of adsorbed molecules on the bulk 
concentration at low concentration regimens and the saturation effect at higher 
adsorbent concentrations [Horbett (1994); Mientus and Knippel (1995)], which was 
quite consistent with our result. Saturation level suggested the formation of monolayer 
of FN on surface, so the extra FN unable to form stable bonding onto the FN 
monolayer, was washed off. Monolayer coverage for proteins theoretically depends 
on the shape and size of the protein molecules as well as on its mode of adsorption. 
Varying monolayer coverage of protein surface density has been reported to range 
between 200ng/cm2 to 500ng/cm2 [Rezania and Healy (1999); Lhoest et al (1998)].  In 
this experiment, we reported a saturation surface density around 400 ng/cm2. 
Although we could not compare the adsorbed FN with soluble FN by ELISA or cell 
adhesion, the AFM photos showed that the adsorbed FN kept its global compact 
conformation, uniformly distributed on the surface, having less structure alteration 
compared with conjugated FN. 
 
6.3.3 FN conjugation and fibrillogenesis 
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In solution, the compact conformation of FN is maintained by only a small 
number of electrostatic associations between distant segments of the molecule: III12–
14/ III2–3, and III12–14/ amino-terminal Heparin I domains [Johnson et al (1999)]. 
However the electrostatic associations can be destroyed in a regulated stepwise 
process, fibrillogenesis, in which soluble FN is converted into insoluble fibrillar 
network. In initiation process: integrins at cells surface recognize the cell-binding 
domains of FN, usually α5β1 binding to RGD domains or α4β1 binding to CS domains. 
It induces FN unfolding that exposes FN binding sites and promotes intermolecular 
interactions with other FN. Finally the integrins clustering and binding of additional 
FN leads to fibril formation [Bentley et al (1985); Patynowski and Schwarzbauer 
(2003)].  
According to the protein immobilization result and morphology observed in 
AFM, we hypothesize a cell-free fibrillogenesis model in the conjugation process 
(Figure 24). At first the amino groups of the protein were randomly immobilized to 
the surface, which helped FN to unfold. While the positive charged amino groups 
were strongly immobilized to the substrate, the negative charged domains of the 
protein were driven away from the surface, forming a negative charge concentrated 
“surface”.  This negatively charged “surface” could immobilize the amino groups of 
the FN by electrostatic association, help the FN unfold, and form new adsorption 
“surface” repeatedly. Thus it formed the multiple layers of FN onto the surface, and 
initiated the fibrillogenesis process.  In summary, this proposed model showed that 
the orientation of the FN molecules on amino groups conjugated surface and 
subsequent unfolding of the molecule may be the key to the induction of 
fibrillogenesis. At high surface charge densities, the created electric field would repel 
the negative domains and strongly attract the positive domains, leaving open and 
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accessible the domains implicated in the fibrillogenesis process. By this model we can 
explain how conjugation method stably immobilized multiple layers of FN, and how 
fibrils like structure formed on surface. Pernodet also reported similar cell-free 
fibrillogenesis on surfonated polystyrene surface after 130 hours of 100ug/ml FN 
[Pernodet et al (2003)]. Compared his result, our conjugation method showed more 
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Figure 24 Hypothetical schemes of FN fibrillogenesis in conjugation process. A: 
Compact conformation of FN in solution is stabilized by III12-14/III2-3 
and III12-14/I domains. B: FN unfolds when the amino groups of the FN 
are immobilized to the surface. C: The unfolded FN exposes new layer of 
negatively charged “surface” for extra FN adsorption. D: FN adsorbes and 
partially unfoldes on the FN layer through electronic association, exposes 
new “surface” for FN adsorption.  
It is increasingly apparent that FN matrix can have profound effects on cell 
functions. Data from structural modeling of repeat III10 indicate that the unfolding of 
the FN and the following fibrillogenesis process might control the accessibility of the 
RGD sequence, and enable cells to retract from FN matrices in order to migrate and 
proliferate [Krammer et al (1999)]. Data from endothelial cells adhering assays, also 
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reported that after fibrillogenesis on endothelial cells surface, the FN matrix prevent 
the extra cells adhering [Dekker et al (1993)]. Our experiment also showed that the 
conjugation induced fibrillogenesis suppressed the accessibility of RGD domains, also 
suppressed cells adhesion, which was quite consistent with the literature mentioned 
above.   
In summary this project studied the regulation of FN involved cell-material 
interaction at the level of FN immobilization methods. In the adsorption method, FN 
adsorbed as isolated molecules or as a monolayer of protein, and preserved higher 
bioactivity in maintaining more RGD domains and favoring cells adhesion. The 
conjugation method induced FN fibrillogenesis, which maintained less RGD domains 
and suppressed cells adhesion. The combination of these two methods may offer us 
the ability to readily control the degree of surface bioactivity, which has particular 
significance to the biomaterials applications like microenvironment reconstruction. It 
has been noted that it is a relatively easy task to generate a highly adhesive substrate 
by direct adsorption of cells adhesion molecules like FN. However a difficulty often 
encountered in application is the inability of cells, once attached to an overly adhesive 
bridging substrate, to leave the material surface for the comparatively less adhesive 
surrounding [Schwab and Bartholdi (1996)]. In this regard, promoting cell migration 
away from the device surface probably will require that the surface become less 
adhesive in comparison with surrounding tissue, which often is not recognized in the 














The ultimate goal of this thesis project was to develop a HSC ex vivo 
expansion system that would be able to produce sufficient and functional HSCs for 
the allogeneic transplantation of CB. To fulfill this goal, we aimed to design an 
artificial microenvironment that mimicked the hematopoiesis process in vivo, which 
can efficiently expanded the cell number and still maintained the “stemness” of the 
cells. 
We chose MSC, non hematopoietic, well-characterized skeletal and 
connective tissue progenitor cells within the bone marrow, as stroma to support HSC 
expansion ex vivo.  First, MSC is relatively easy to harvest and culture ex vivo. MSC 
provides a rich environment of signals, including cytokines, ECM proteins, adhesion 
molecules, and cell-cell interactions, controlling the proliferation, survival, and 
differentiation of early lympho- hematopoietic stem cells [Haynesworth et al (1996), 
Majumdar et al (2000)]. What is more, MSCs, like other stem cells, are poor antigen 
presenting and relatively immunologically compatible. 
In this study we clearly demonstrated the benefit of MSC inclusion in HSC 
expansion ex vivo.  We tested the co culture result under different conditions: fresh 
stroma & irradiated stroma co-culture; stroma exchanged & non stroma exchanged 
co-culture; feeder layer & pellet co-culture; contact & non-contact co-culture; 2D & 
3D co-culture. The results showed that MSC can survive in the serum free StemSpan 
medium supplemented with growth factors and LDL. MSC’s metabolic level affected 
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the expansion result. Neither too low nor too high metabolic level was favorable for 
CB CD34+ cells expansion.  
Compared with non-contact co-culture in transwell system, contact co-culture 
increased higher expansion of total cells (545.4 vs.316.5 fold; p<0.05), CD34+ cells 
(47.9 vs. 21.1 fold; p<0.05), CD34+CD38- cells (100.4 vs. 52.8 fold; p<0.05). Similarly, 
the pluripotency of cells expanded in contact co-culture as evaluated by CFC assay was 
also superior compared to those expanded in non-contact co-culture (CFU-GEMM: 
84.1 vs. 76.0 fold; total CFU 150.1 vs. 116.5 fold; p<0.05). The animal engraftment 
assays also showed that cells expanded in contact co-culture system appeared to be 
more competent in reconstructing short term hematopoiesis. These results suggested 
that cell-cell contact was required for the further expansion of stem cells; only growth 
factors in conditioned medium could not fully replace the function of stroma. The long 
term tracing staining- CMFDA experiment showed that about 1.6% of the expanded 
cells had communicated with stroma in culture, which were stained with CMFDA. And 
63.9% of these CMFDA+ cells expressed CD34 surface marker, which was about 8 
times higher than CMFDA- suspension cells. The results highly suggested that cell-cell 
communication existed between MSCs and CB cells in contact co-culture, and that 
kind of cell-cell communication helped to reserve stem cells primitivity and prevent 
them from differentiation.  
 The conformation of the co-culture system also significantly affected stem 
cells expansion. The result showed that the direct contact between MSC and HSC in 
3D cultures led to statistically-significant higher expansion of CB CD34+ cells 
compared to 2D co-cultures: 891- versus 545-fold increase in total cells, 96- versus 
48-fold increase of CD34+ cells, and 230- versus 150-fold increase in CFC. 
NOD/SCID mouse engraftment assays also indicated a high success rate of 
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hematopoiesis reconstruction with these expanded cells. Cytochemical staining 
revealed that culture of MSCs on 3D mesh led to increased proliferation which may 
contribute to the increase in beneficial effects on CB expansion. More importantly, we 
observed high expression of ECM fibrils on MSCs grown in 3D culture, especially 
FN, a feature not seen for cells grown on 2D culture. This 3D scaffold induced fibrous 
structure and excessive expression of ECM protein facilitated and regulated CB 
CD34+ cells expansion, which probably explained the enhanced result.  
Inspired by the finding that FN was the mainly expressed ECM protein by 
MSCs, and FN’s influence in HSC cell cycle [Dao et al (1998)], we hypothesize that 
the immobilization of ECM protein FN onto the surface of culture systems might 
represent another stroma free expansion strategy. A key problem in FN 
immobilization is the change of bioactivity during the immobilization process. We 
studied FN bioactivity after two common immobilization pathways: conjugation and 
adsorption, we found a way to control the function of the immobilized protein on the 
level of immobilization methods, which can be helpful for the construction of an 
artificial niche in the future. The adsorption method maintained a normal 
conformation of FN, leading to less change of its bioactivity in the access of RGD 
domains and cell adhesion ability. The covalent conjugation process, on the other 
hand, induced FN unfolding and fibrillogenesis ex vivo, which blocked the access of 
active RGD domains and suppressed fibroblast cells adhesion. The HSC expansion on 
these FN immobilized scaffolds also showed very promising results [Q. Feng et al, 
unpublished data]. 
Taken together, we designed a 3D bio-artificial “niche” coupled with elevated 
deposition of ECM by MSC, which more closely resembled the natural bone marrow 
microenvironment; therefore, it favored CD34+ cell proliferation and maintenance of 
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pluripotency. We also studied FN bioactivity after immobilization, which helped us to 
construct another stroma free system supporting CD34+ cells expansion. 
 
7.2 Future prospect  
In summary, a great deal of experiences over the past 15 years in terms of the 
ability to isolate and culture primitive hematopoietic stem and progenitor cells has 
been attempted. Especially the research in growth factors and other soluble factors of 
stem cell proliferation have provided great insight into the biology of stem cells, but 
we do not yet understand how to organize these molecules in a physiologically 
relevant manner. The perpetual discoveries in molecular biology and developmental 
biology help this process cooperatively. For example, recently Lodish group isolated a 
new kind of HSC-supportive cells: mouse fetal liver CD3+ cells. Subsequently, they 
identified two growth factors: angiopoietin like 2 and angiopoietin like 3 specially 
expressed by these HSC-supportive cells by microarray expression analysis.  The 10 
days expansion in the presence of these two factors, induced up to 30 net expansion of 
long-term HSC by reconstitution analysis, which was the highest stem cell expansion 
that had ever been reported [Zhang et al 2006]. These researches pave the way to the 
establishment of the procedure for clinical application and build up hope for these 
patients.  
However, there is still a long way to translate these research results into clinics.  
To be widely accepted, procedures for ex vivo stem cell expansion will have to meet 
the requirements of Federal Good Manufacturing Practices (GMPs). The key concepts 
of GMPs are: 
o Preventing the transmission of communicable disease. 
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o Processing controls, for example, prevent contamination and preserve integrity 
and function. 
o Assuring clinical safety and effectiveness, especially with presence of 
allogeneic materials, for example the allogeneic MSC in this study 
That is to say products (for infusion) must be produced in a manner that ensures that 
they are safe and (reproducibly) fit for their intended use.  
So far, we seem to only have safety data. Studies Allogeneic MSC expanded 
in culture could be successfully co-infused with T-cell depleted peripheral blood 
hematopoietic progenitors into a haploidentical receipient and it is currently under 
further clinical evaluation [Lee et al (2002)]. And a short term standard lymphocytes 
mixture test is recommended before transplantation, to make sure expanded cells with 
MSCs will not induce immunological reaction.  
The uniformity and effectiveness of expanded products is still under the 
developmental stages. As mentioned before, the main limit of CB allogeneic 
transplantation is insufficient cells number. In transplantation CB nucleated cells, 
about 2,500,000 CD34+ cells per kg body weight is required [Koller et al 1973]. 
Therefore, for a patient of 70 kg body weight, 175,000,000 CD34+ cells are required. 
Based on the 3D co-culture system mentioned above, 96-fold expansion of CD34+ 
cells can be achieved.  about 1,820,000 CD34+ cells are required to start expansion. 
More than 3000 scaffolds are needed, which is quite unpractical. A clinical-scale 
bioreactor must be developed to accommodate large number of cells and scaffolds 
with high cell densities. With this developed culture system of sufficient simplicity, 
flexibility and economic efficacy, the true potential of ex vivo expansion of HSCs that 
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